¥Û¡¼¥à > »À²½¥¹¥È¥ì¥¹¥Þ¡¼¥«¡¼µ»½Ñ¾ðÊó¡Ê¥Ú¡¼¥¸ 1 /  2 /  3 /  4 /  5 /  6 /  7 /  8 /  9 /  10 /  11 /  12 /  13 /  14 /  15  ¡Ë
»À²½¥¹¥È¥ì¥¹¥Þ¡¼¥«¡¼µ»½Ñ¾ðÊó
Technical support for oxidative stress biomarkers.  
¤³¤Á¤é¤Ç¤Ï»À²½¥¹¥È¥ì¥¹¥Þ¡¼¥«¡¼¤Îµ»½Ñ¾ðÊ󡢳ؽѾðÊó¤ò¤´¾Ò²ð¤·¤Æ¤ª¤ê¤Þ¤¹¡£³§ÍͤΤ´¸¦µæ¤ËÌòΩ¤Æ¤Æ失¤ì¤Ð ¹¬¤¤¤Ç¤¹¡£
¤Þ¤¿¤è¤í¤·¤±¤ì¤Ð¡¢³Ø²ñ¤äÏÀʸÅù¤Çȯɽ¤µ¤ì¤¿ÆâÍƤò¤´¾Ò²ð失¤ì¤ÐÂçÊѤ¢¤ê¤¬¤¿¤¯»×¤¤¤Þ¤¹¡£
¤´¼ÁÌ䡦¥³¥á¥ó¥È¤Ê¤É¤ªµ¤·Ú¤Ë¤ªÁ÷¤ê失¤ë¤È½õ¤«¤ê¤Þ¤¹¡£ biotech@jaica.com¤Þ¤Ç¤ªµ¤·Ú¤Ë¤ªÃΤ餻¤¯¤À¤µ¤¤¡£
ÂоݤȤʤë¥Þ¡¼¥«¡¼¤â½ù¡¹¤ËÁý¤ä¤·¤Æ¤¤¤­¤¿¤¤¤È»×¤¤¤Þ¤¹¡£¤É¤¦¤¾¤è¤í¤·¤¯¤ª´ê¤¤¿½¤·¾å¤²¤Þ¤¹¡£

ÊÀ¼Ò¤ÏËÜ¥Û¡¼¥à¥Ú¡¼¥¸¤ª¤è¤ÓÀ½ÉÊ¡¢ÅºÉÕʸ½ñÅù¤òºîÀ®¤¹¤ë¤Ë¤¢¤¿¤êºÙ¿´¤ÎÃí°Õ¤òʧ¤Ã¤Æ¤ª¤ê¤Þ¤¹¤¬¡¢¤³¤ì¤é¤Ë¤è¤ë»³²¤¬Ëü°ìȯÀ¸¤·¤¿¾ì¹ç¤Ç¤â¡¢ ÊÀ¼Ò¤ÏÀÕ¤òÉ餤¤Þ¤»¤ó¤Î¤Çͽ¤á¤´Î»¾µ¤¯¤À¤µ¤¤¡£¤Þ¤¿¡¢À½ÉʤβÁ³Ê¡¢»ÅÍÍ¡¢»îÌô¹½À®¡¢Â¬Äê¼ê½çÅù¤Ï¡¢À½Â¤¸µ¤ÎÅÔ¹ç¤Ë¤è¤êͽ¹ð̵¤¯Êѹ¹¤µ¤ì¤ë ¾ì¹ç¤¬¤¢¤ê¤Þ¤¹¡£
ʬ
Îà
À½ÉÊ̾ ¡Ê²¼µ­¤ò¥¯¥ê¥Ã¥¯¡Ë

³Ë
»À

New/¹â´¶ÅÙ8-OHdG Check µ»½Ñ¾ðÊó ʸ¸¥
¹³8-OHdG¥â¥Î¥¯¥í¡¼¥Ê¥ë¹³ÂÎ µ»½Ñ¾ðÊó ʸ¸¥
¹³TG¥â¥Î¥¯¥í¡¼¥Ê¥ë¹³ÂÎ µ»½Ñ¾ðÊó ʸ¸¥

Ȏ
¼Á
»À
²½

¥Ø¥­¥µ¥Î¥¤¥ë¥ê¥¸¥ó(HEL)¬Äꥭ¥Ã¥È µ»½Ñ¾ðÊó ʸ¸¥
¹³HEL¥â¥Î¥¯¥í¡¼¥Ê¥ë¹³ÂÎ µ»½Ñ¾ðÊó ʸ¸¥
¹³4-HNE¥â¥Î¥¯¥í¡¼¥Ê¥ë¹³ÂÎ µ»½Ñ¾ðÊó ʸ¸¥
Ç¢Ã楤¥½¥×¥é¥¹¥¿¥ó¬Äꥭ¥Ã¥È µ»½Ñ¾ðÊó ʸ¸¥
·ìÀ¶¥¤¥½¥×¥é¥¹¥¿¥ó¬Äꥭ¥Ã¥È µ»½Ñ¾ðÊó ʸ¸¥
¥Þ¥í¥ó¥¸¥¢¥ë¥Ç¥Ò¥É(MDA)¬Äꥭ¥Ã¥È µ»½Ñ¾ðÊó ʸ¸¥
¥Þ¥í¥ó¥¸¥¢¥ë¥Ç¥Ò¥É(MDA)ELISA¬Äꥭ¥Ã¥È µ»½Ñ¾ðÊó ʸ¸¥
¹³¥Þ¥í¥ó¥¸¥¢¥ë¥Ç¥Ò¥É(MDA)¹³ÂÎ µ»½Ñ¾ðÊó ʸ¸¥
¥Ò¥È»À²½LDL ¬Äꥭ¥Ã¥È µ»½Ñ¾ðÊó ʸ¸¥
¥Ò¥È»À²½LDL ¼«¸Ê¹³ÂάÄꥭ¥Ã¥È µ»½Ñ¾ðÊó ʸ¸¥
¹³¥Ò¥È»À²½LDL¹³ÂÎ µ»½Ñ¾ðÊó ʸ¸¥
¹³¥¢¥¯¥í¥ì¥¤¥ó(ACR)¹³ÂÎ µ»½Ñ¾ðÊó ʸ¸¥
¹³4-HHE¥â¥Î¥¯¥í¡¼¥Ê¥ë¹³ÂÎ µ»½Ñ¾ðÊó ʸ¸¥
¹³¥¯¥í¥È¥ó¥¢¥ë¥Ç¥Ò¥É(CRA)¹³ÂÎ µ»½Ñ¾ðÊó ʸ¸¥
¹³7¥±¥È¥³¥ì¥¹¥Æ¥í¡¼¥ë(7-KC)¹³ÂÎ µ»½Ñ¾ðÊó ʸ¸¥
¥¢¥¯¥í¥ì¥¤¥ó¬ÄêÍÑELISA¥­¥Ã¥È¡ÊÈÎÇ佪λ¡Ë µ»½Ñ¾ðÊó ʸ¸¥

Åü

¹³N¦Å-(carboxymethyl)lysine: CML¹³ÂÎ µ»½Ñ¾ðÊó ʸ¸¥
¹³¥á¥Á¥ë¥°¥ê¥ª¥­¥¶¡¼¥ë(MG)¹³ÂÎ µ»½Ñ¾ðÊó ʸ¸¥

ÃÁ
Çò
¼Á

»À
²½

¥«¥ë¥Ü¥Ë¥ë²½ÃÁÇò¬Äꥭ¥Ã¥È µ»½Ñ¾ðÊó ʸ¸¥
¥«¥ë¥Ü¥Ë¥ë²½ÃÁÇò¬Äꥭ¥Ã¥È(ŽËŽÄ/ưʪÍÑ) µ»½Ñ¾ðÊó ʸ¸¥
¥Ò¥È·ìÀ¶ ¥«¥ë¥Ü¥Ë¥ë²½ÃÁÇò¼Á ¬Äꥭ¥Ã¥È µ»½Ñ¾ðÊó ʸ¸¥
¥¿¥ó¥Ñ¥¯¼Á²á»À²½Êª(AOPP)¬Äꥭ¥Ã¥È µ»½Ñ¾ðÊó ʸ¸¥
·ìÞù¥Ë¥È¥í¥Á¥í¥·¥ó(NT)¬Äꥭ¥Ã¥È µ»½Ñ¾ðÊó ʸ¸¥
¥Ë¥È¥í¥Á¥í¥·¥ó(NT)¬Äꥭ¥Ã¥È µ»½Ñ¾ðÊó ʸ¸¥
¹³¥Ë¥È¥í¥È¥ê¥×¥È¥Õ¥¡¥ó(NW)¥â¥Î¥¯¥í¡¼¥Ê¥ë¹³ÂÎ µ»½Ñ¾ðÊó ʸ¸¥
¥¸¥Á¥í¥·¥ó(DT)¬Äꥭ¥Ã¥È µ»½Ñ¾ðÊó ʸ¸¥
¹³¥¸¥Á¥í¥·¥ó(DT)¥â¥Î¥¯¥í¡¼¥Ê¥ë¹³ÂÎ µ»½Ñ¾ðÊó ʸ¸¥
¹³¥¸¥Ö¥í¥â¥Á¥í¥·¥ó(DiBrY)¥â¥Î¥¯¥í¡¼¥Ê¥ë¹³ÂÎ µ»½Ñ¾ðÊó ʸ¸¥
     
ʬ
Îà
À½ÉÊ̾ ¡Ê²¼µ­¤ò¥¯¥ê¥Ã¥¯¡Ë
¹³
»À
²½
¡¦
±ê
¾É
´Ø
Ï¢
¹Ú
ÁÇ
SOD³èÀ­Â¬Äꥭ¥Ã¥È¡ÊÈ濧ˡ¡Ë µ»½Ñ¾ðÊó ʸ¸¥
¥Ò¥ÈCu/Zn-SOD ELISA¥­¥Ã¥È(SOD1) µ»½Ñ¾ðÊó ʸ¸¥
¥Ò¥ÈMn-SOD ELISA¥­¥Ã¥È(SOD2) µ»½Ñ¾ðÊó ʸ¸¥
¥Ò¥Èec-SOD ELISA¥­¥Ã¥È(SOD3) µ»½Ñ¾ðÊó ʸ¸¥
¥«¥¿¥é¡¼¥¼³èÀ­Â¬Äꥭ¥Ã¥È(CAT) µ»½Ñ¾ðÊó ʸ¸¥
¥°¥ë¥¿¥Á¥ª¥ó¥Ú¥ë¥ª¥­¥·¥À¡¼¥¼(GPx)¬Äꥭ¥Ã¥È µ»½Ñ¾ðÊó ʸ¸¥
¥°¥ë¥¿¥Á¥ª¥ó¥ì¥À¥¯¥¿¡¼¥¼(GR)¬Äꥭ¥Ã¥È µ»½Ñ¾ðÊó ʸ¸¥
¥Ò¥ÈºÙ˦¼ÁGPx ELISA¥­¥Ã¥È µ»½Ñ¾ðÊó ʸ¸¥
GST-¦Ð¬Äꥭ¥Ã¥È µ»½Ñ¾ðÊó ʸ¸¥
·ìÀ¶¥ß¥¨¥í¥Ú¥ë¥ª¥­¥·¥À¡¼¥¼(MPO)¬Äꥭ¥Ã¥È µ»½Ñ¾ðÊó ʸ¸¥
Ç¢Ãæ¥ß¥¨¥í¥Ú¥ë¥ª¥­¥·¥À¡¼¥¼(MPO)¬Äꥭ¥Ã¥È µ»½Ñ¾ðÊó ʸ¸¥
·ìÀ¶MPO³èÀ­Â¬Äꥭ¥Ã¥È µ»½Ñ¾ðÊó ʸ¸¥
PMN¥¨¥é¥¹¥¿¡¼¥¼Â¬Äꥭ¥Ã¥È µ»½Ñ¾ðÊó ʸ¸¥
¥ì
¥É
¥Ã
¥¯
¥¹
¡¦
Ï·
²½
À©
¸æ
¥Ñ¥é¥ª¥­¥½¥Ê¡¼¥¼(arylesterase³èÀ­)¬Äꥭ¥Ã¥È µ»½Ñ¾ðÊó ʸ¸¥
¥Ñ¥é¥ª¥­¥½¥Ê¡¼¥¼(paraoxonase³èÀ­)¬Äꥭ¥Ã¥È µ»½Ñ¾ðÊó ʸ¸¥
¥Á¥ª¥ì¥É¥­¥·¥ó³èÀ­Â¬Äꥭ¥Ã¥È µ»½Ñ¾ðÊó ʸ¸¥
¥Ò¥È ¥Á¥ª¥ì¥É¥­¥·¥óI ELISA¥­¥Ã¥È µ»½Ñ¾ðÊó ʸ¸¥
¥Ò¥È ¥Á¥ª¥ì¥É¥­¥·¥ó´Ô¸µ¹ÚÁÇI ELISA¥­¥Ã¥È µ»½Ñ¾ðÊó ʸ¸¥
¥Ú¥ë¥ª¥­¥·¥ì¥É¥­¥·¥ó³èÀ­Â¬Äꥭ¥Ã¥È µ»½Ñ¾ðÊó ʸ¸¥
¥Ò¥È ¥Ú¥ë¥ª¥­¥·¥ì¥É¥­¥·¥óI ELISA¥­¥Ã¥È µ»½Ñ¾ðÊó ʸ¸¥
¥Ò¥È ¥Ú¥ë¥ª¥­¥·¥ì¥É¥­¥·¥óIII ELISA¥­¥Ã¥È µ»½Ñ¾ðÊó ʸ¸¥
¥Á¥ª¡¼¥ë¥¹¥Æ¡¼¥¿¥¹Â¬Äꥭ¥Ã¥È µ»½Ñ¾ðÊó ʸ¸¥
¥Ò¥È ¥ß¥ª¥¹¥¿¥Á¥ó¬Äꥭ¥Ã¥È µ»½Ñ¾ðÊó ʸ¸¥

¹³
»À
²½

¹³»À²½Ç½Â¬Äꥭ¥Ã¥È¡ÖPAO/PAO-U¡× µ»½Ñ¾ðÊó ʸ¸¥
¹³»À²½Ç½Â¬Äꥭ¥Ã¥È¡ÊÌý»éÍÑ¡Ë¡ÖPAO-SO¡× µ»½Ñ¾ðÊó ʸ¸¥
¥°¥ë¥¿¥Á¥ª¥ó¬Äꥭ¥Ã¥È µ»½Ñ¾ðÊó ʸ¸¥
¥Ó¥¿¥ß¥óC¬Äꥭ¥Ã¥È µ»½Ñ¾ðÊó ʸ¸¥
¥Ú¥ë¥ª¥­¥·¥ë¥é¥¸¥«¥ë¾Ãµî³èÀ­Â¬Äꥭ¥Ã¥È µ»½Ñ¾ðÊó ʸ¸¥

¾

14,15-DHET¬Äꥭ¥Ã¥È¡Ê¹â·ì°µ¸¦µæ¥Þ¡¼¥«¡¼¡Ë µ»½Ñ¾ðÊó ʸ¸¥
     
     
ÀèÀ¸¤Î¤´¸¦µæ¤ò¤´¾Ò²ð¤¯¤À¤µ¤¤¡£¤´¼ÁÌä¤â¤ªµ¤·Ú¤Ë¤É¤¦¤¾¡Ê¥á¡¼¥ë¡Ë
¥Þ¥í¥ó¥¸¥¢¥ë¥Ç¥Ò¥É(MDA¡¦TBARSË¡) ¬Äꥭ¥Ã¥È
No. ¡Ú¥¿¥¤¥È¥ë¡Û ¡ÚÆâÍÆ¡Û
1 ·ìÀ¶Ãæ¤ÎMDA¬Äê ·ìÀ¶Ãæ¤ÎMDA¤â¸¡½Ð²Äǽ¤Ç¤¹¡£ ·ìÀ¶¥µ¥ó¥×¥ë¤Î¾ì¹ç¡¢¥Ð¥Ã¥¯¥°¥é¥¦¥ó¥É¤¬¹â¤¯¤Ê¤ë¤³¤È¤¬ÃΤé¤ì¤Æ¤ª¤ê¡¢¥Ð¥Ã¥¯¥°¥é¥¦¥ó¥É¤Î±Æ¶Á¤òÈò¤±¤ë¤¿¤á¤Ë third derivative analysis½èÍý¤ò¤ª¾©¤á¤·¤Þ¤¹¡£ ¾ÜºÙ¤Ï¤³¤Á¤é(PDF: Ìó3.7MB) ¤ò¤´Í÷¤¯¤À¤µ¤¤¡£ ¾°¡¢·ìÀ¶¥µ¥ó¥×¥ë¤Ï-70¡î¤Ë¤ÆÅà·ëÊݸ¤·¤Æ¤¯¤À¤µ¤¤¡£

¥Ð¥Ã¥¯¥°¥é¥¦¥ó¥É¤Î¼ç¤ÊÍ×°ø¤Ç¤¢¤ë¥Ø¥â¥°¥í¥Ó¥ó¤òÃê½Ð¤¹¤ë¤³¤È¤Ç¡¢2ÇÈŬ¸÷¡ÊJentzschË¡¡§535nm¤È572nm¡Ë¤Ç¤â ÀºÅ٤ι⤤¥Ç¡¼¥¿¤òÆÀ¤ë¤³¤È¤¬¤Ç¤­¤Þ¤¹¡£

ËÜ¥­¥Ã¥È¤Ë¤è¤ë¥Ò¥ÈÀµ¾ï·ìÀ¶Â¬ÄêÎ㡧0.25¦ÌM
2 Third delivative analysis¤È¤Ï µÛ¸÷Å٤ΥХ寥°¥é¥¦¥ó¥É¤ò¾Ãµî¤¹¤ë¤¿¤á¤Î²òÀÏÊýË¡¤Ç¤¹¡£¤Þ¤º¡¢Ê¬¸÷¸÷Åٷפò»È¤Ã¤ÆÇÈĹ400nm¤«¤é 700nm¤Þ¤Ç¤ÎµÛ¸÷ÅÙ¤ò1nm¤Þ¤¿¤Ï2nm¹ï¤ß¤Ç·×¬¤·¤Þ¤¹¡£ À½Â¤¸µ¡ÊNorthwest Life Science Specialities LLC¡Ë¤Î¥¦¥§¥Ö¥µ¥¤¥È¤Ë¤Æ¡¢¥ª¥ó¥é¥¤¥ó¤Ç ¥Ç¡¼¥¿²òÀϤò¤¹¤ë¤³¤È¤¬¤Ç¤­¤Þ¤¹¡£http://www.nwlss.com/sg/worksheet.php

²òÀÏÊýË¡¤Î¾ÜºÙ¡¢¥ª¥ó¥é¥¤¥ó²òÀϤλÈÍÑÊýË¡¤Ë¤Ä¤­¤Þ¤·¤Æ¤Ï¡¢¤³¤Á¤é¤ò¤´Í÷¤¯¤À¤µ¤¤¡£
3 ÁÈ¿¥¥Û¥â¥¸¥Í¡¼¥È¤Ø¤ÎŬÍÑ
¡Ê¥Þ¥¦¥¹Ç¾ÁÈ¿¥¤Ø¤ÎŬÍÑÎã¡Ë
ËÜ¥­¥Ã¥È¤ÏÁÈ¿¥¥Û¥â¥¸¥Í¡¼¥È¤Ë¤âŬÍѲÄǽ¤Ç¤¹¡£É¹Î䤷¤¿¥¢¥Ã¥»¥¤¥Ð¥Ã¥Õ¥¡¡¼¤ÈÁÈ¿¥¤òº®¹ç¤·¡¢ 10%(W/V)¥Û¥â¥¸¥Í¡¼¥È¤òDounce·¿¤Þ¤¿¤ÏPotter-Elvehjem·¿¤Î¥Û¥â¥¸¥Ê¥¤¥¶¡¼¤ò»È¤Ã¤ÆÄ´À½¤·¤Þ¤¹¡£ ±ó¿´¾åÀ¶¤ò²ó¼ý¤·¤ÆɹÎ䤷¡¢Ä¾¤Á¤ËMDA¤ò¬Äꤷ¤Þ¤¹¡£
¡¦É¬Íפʥµ¥ó¥×¥ëÎ̤ϡ¢ÁÈ¿¥¤Î¼ïÎࡢưʪ¼ï¡¢»À²½¥¹¥È¥ì¥¹¤Î¾õ¶·¤Ë¤è¤ê°Û¤Ê¤ê¤Þ¤¹¡£¸¡½Ð²¼¸Â¤È¤Ê¤Ã¤¿¾ì¹ç¤Ë¤Ï ÁÈ¿¥Î̤òÁý¤ä¤·¤Æ¬Äꤷ¤Æ¤¯¤À¤µ¤¤¡£
¡¦¥Ø¥â¥°¥í¥Ó¥ó¤¬´³¾Ä¤¹¤ë²ÄǽÀ­¤¬¤¢¤ë¤¿¤á¡¢ÁÈ¿¥¤Ë¤è¤êŬÀڤʥХåե¡¡¼¡ÊÎ㡧¥Ø¥Ñ¥ê¥ó´ÞÍ­ À¸ÍýŪ¥ê¥ó»À´Ë¾×±Õ¡Ë¤Ç Þõή¤·¤¿Êý¤¬Îɤ¤¾ì¹ç¤¬¤¢¤ê¤Þ¤¹¡Ê¥Þ¥¦¥¹Ç¾¤Ø¤ÎŬÍѤǤÏÞõή¤ÎɬÍ×À­¤Ï̵¤¤¤è¤¦¤Ç¤¹¡Ë¡£
¡¦¥µ¥ó¥×¥ë½èÍýÃæ¤Î»é¼Á»À²½¤òÍÞÀ©¤¹¤ë¤¿¤á¤Ë¥Û¥â¥¸¥Í¡¼¥È¤ËBHT(0.1%ÄøÅÙ)¤òź²Ã¤¹¤ë¤³¤È¤ò¤ª¾©¤á¤·¤Þ¤¹¡£
¡¦¥µ¥ó¥×¥ë¤ÎÊݸ¤Ï¡¢ÁÈ¿¥¥Ö¥í¥Ã¥¯¤Î¾õÂÖ¤Ç-80¡î¤Ë¤Æ¹Ô¤Ã¤Æ¤¯¤À¤µ¤¤¡£
¡¦Â¬Äê¥Ç¡¼¥¿¤ÎÊäÀµ¤Ï¡¢ÁÈ¿¥¤Î¼¾½ÅÎ̤ޤ¿¤Ï¡¢¥Û¥â¥¸¥Í¡¼¥ÈÃæ¤ÎÃÁÇòÇ»Å٤ǹԤ¦¤³¤È¤¬²Äǽ¤Ç¤¹¡£
4 ¥Þ¥¦¥¹´Î¡¤Ø¤ÎŬÍÑ ËÜ¥­¥Ã¥È¤Ï¥Þ¥¦¥¹´Î¡¤Ë¤âŬÍѲÄǽ¤Ç¤¹¡£
5 ¥Ø¥â¥°¥í¥Ó¥ó¤Î½üµîÊýË¡
¡Ê¥Ð¥Ã¥¯¥°¥é¥¦¥ó¥ÉÂкö¡Ë
¥Ø¥â¥°¥í¥Ó¥ó¤ÏTBA2-MDA¤Ë¶á¤¤ÇÈĹ¤Ç¤ÎµÛ¼ý¤ò¼¨¤¹¤¿¤á¡¢¥µ¥ó¥×¥ëÃæ¤Ë¹âÇ»Å٤˴ޤޤì¤Æ¤¤¤ë¤È ¬ÄêÃͤ˱ƶÁ¤òÍ¿¤¨¤ë¾ì¹ç¤¬¤¢¤ê¤Þ¤¹¡£¥µ¥ó¥×¥ë¤«¤é¥Ø¥â¥°¥í¥Ó¥ó¤ò½üµî¤¹¤ë¤³¤È¤Ç¡¢¤è¤êÀµ³Î¤ËMDA¤ò ¬Äê¤Ç¤­¤ë¤è¤¦¤Ë¤Ê¤ê¤Þ¤¹¡£
MDA¬ÄêÍÑ ¥Ø¥â¥°¥í¥Ó¥ó½üµî¥×¥í¥È¥³¥ë

¾åµ­¤Î¥×¥í¥È¥³¥ë¤Ç¤Ï¡¢500¦ÌL¤ÎÈ¿±þ±Õ¤¬ÆÀ¤é¤ì¤Þ¤¹¡£¤ª»È¤¤¤Îʬ¸÷¸÷ÅٷפΥ»¥ë¤ÎÍÆÀѤ˹ç¤ï¤»¤Æ ¥¹¥±¡¼¥ë¥¢¥Ã¥×/¥¹¥±¡¼¥ë¥À¥¦¥ó¤ò¹Ô¤Ã¤Æ¤¯¤À¤µ¤¤¡£
6 ¥Ø¥â¥°¥í¥Ó¥ó½üµî¤ËɬÍפʻîÌô ¥Ø¥â¥°¥í¥Ó¥ó½üµî½èÍý¤ËɬÍפʻîÌô¤Ï¡¢²¼µ­¤ÎÊýË¡¤ÇÄ´À½¤·¤Þ¤¹¡£
1) ¥Ö¥¿¥Î¡¼¥ë¡§ »ÔÈÎ1-butanol¤ò¤½¤Î¤Þ¤Þ»ÈÍѤ·¤Þ¤¹¡£
¡ÊÎ㡧ϸ÷½ãÌô¹©¶È Code. 020-16031, 100mL¡Ë
2) 1N NaOH¡§ ¿å»À²½¥Ê¥È¥ê¥¦¥à¤ò¾øα¿å¤ËÍϲò¤·¤ÆÄ´À½¤·¤Þ¤¹¡£
3) 3.7M ¥ê¥ó»À¡§ »ÔÈÎ¥ê¥ó»À¤ò¾øα¿å¤Ë¤Æ´õ¼á¤·¤ÆÄ´À½¤·¤Þ¤¹¡£
¡ÊÎ㡧ϸ÷½ãÌô¹©¶È code. 167-02161, 100mL¡Ë
7 ¥Ø¥â¥°¥í¥Ó¥ó½üµî¤Î¥Ö¥¿¥Î¡¼¥ë²èʬ ¥µ¥ó¥×¥ë¤ÎÀ­¾õ¤Ë¤è¤ê¡¢¥Ø¥â¥°¥í¥Ó¥ó½üµîÁàºî¤Ë¤ª¤¤¤Æ½½Ê¬¤ÊÎ̤Υ֥¿¥Î¡¼¥ë²èʬ¤¬²ó¼ý¤Ç¤­¤Ê¤¤¾ì¹ç¤¬ ¤¢¤ë¤è¤¦¤Ç¤¹¡£¤³¤Î¤è¤¦¤Ê¥±¡¼¥¹¤Ç¤Ï¡¢²¼µ­¤Î¤è¤¦¤ÊÂкö¤¬¹Í¤¨¤é¤ì¤Þ¤¹¡£
¡ÚÊýË¡1¡Û: ±ó¿´»þ´Ö¤òŤ¯¤¹¤ë¡£
¡ÚÊýË¡2¡Û: ¥Ö¥¿¥Î¡¼¥ë²èʬ¤Î²ó¼ý±ÕÎ̤¬¾¯¤Ê¤¤¾ì¹ç¡¢°Ê¸å¤ÎÁàºî¤Ë¤Ä¤¤¤Æ¥¹¥±¡¼¥ë¥À¥¦¥ó¤·¤Æ¼Â»Ü¤·¤Þ¤¹¡£ Î㤨¤Ð¥Ö¥¿¥Î¡¼¥ë²èʬ¤ò200¦ÌL²ó¼ý¤·¤¿¾ì¹ç¡ÊÄ̾ïÎ̤Î50¡ó¡Ë¡¢NaOH¿åÍϱդÎź²ÃÎ̤ÏÄ̾ïÎ̤ÎȾʬ¤Î250¦ÌL¤È¤·¡¢ 200¦ÌL¤ò²ó¼ý¡¢3.7M¥ê¥ó»À¤Îź²ÃÎ̤âÄ̾ïÎ̤ÎȾʬ¤Î50¦ÌL¤È¤·¤Þ¤¹¡£
¡ÚÊýË¡3¡Û: Åº²Ã¤¹¤ë¥Ö¥¿¥Î¡¼¥ë¤ÎÎ̤ò500¦ÌL¤è¤ê¿¤¯¤·¤Þ¤¹¡£²ó¼ý¤¹¤ë¥Ö¥¿¥Î¡¼¥ë²èʬ¤ÏÄ̾ïÄ̤ê 400¦ÌL¤È¤·¡¢°Ê¸å¤ÎÁàºî¤âÄ̾ïÄ̤ê¤Î¥×¥í¥È¥³¥ë¤È¤·¤Þ¤¹¡£
Ãí°ÕÅÀ¡§¥µ¥ó¥×¥ë¤À¤±¤Ç¤Ê¤¯¡¢¥¹¥¿¥ó¥À¡¼¥É¤Ë¤Ä¤¤¤Æ¤âɬ¤ºÆ±°ì¤Î¥×¥í¥È¥³¥ë¤òŬÍѤ·¤Æ¤¯¤À¤µ¤¤¡£
8 ¸Â³°ßɲá¤Ë¤è¤ë½üÃÁÇò½èÍý ¥È¥ê·ìÀ¶¤Ë¤Ä¤­¤Þ¤·¤Æ¤Ï¡¢µÛ¸÷¥¹¥Ú¥¯¥È¥ë¤¬MDA¬Äê¤ËÀµ¤Î´³¾Ä¤òÍ¿¤¨¤ë¥±¡¼¥¹¤¬¤¢¤ë¤³¤È¤¬´Ñ»¡¤µ¤ì¤Æ¤ª¤ê¤Þ¤¹¡£ ¤³¤Î¾ì¹ç¡¢¸Â³°ßɲáËì¤ò»ÈÍѤ·¤¿½üÃÁÇò½èÍý¤Ç¡¢±Æ¶Á¤ò½üµî¤¹¤ë¤³¤È¤¬²Äǽ¤Ç¤¹¡£
¸Â³°ßɲá¤ÎÊýË¡¤Ë¤Ä¤­¤Þ¤·¤Æ¤Ï¡Ö·ìÀ¶8-OHdG¤ÎÁ°½èÍýÊýË¡¡×¤ò¤´»²¾È¤¯¤À¤µ¤¤¡£
9 ¥­¥ã¥ê¥Ö¥ì¡¼¥¿¡¼(tetramethoxypropane)¤Ë¤Ä¤¤¤Æ ËÜ¥­¥Ã¥È¤Ç¤Ï¥­¥ã¥ê¥Ö¥ì¡¼¥¿¡¼¤È¤·¤ÆMDA¤Ç¤Ï¤Ê¤¯¡¢MDA¤ÎÈæ³ÓŪ°ÂÄê¤ÊÁ°¶îÂΤǤ¢¤ëtetramethoxypropane¤ò ºÎÍѤ·¤Æ¤ª¤ê¤Þ¤¹¡£tetramethoxypropane¤Ï»ÀÀ­¾ò·ï²¼¤Ç®¤ä¤«¤Ë²Ã¿åʬ²ò¤µ¤ì¡¢MDA¤òÀ¸À®¤·¤Þ¤¹¡£
10 ¥¢¥Ã¥»¥¤¥Ð¥Ã¥Õ¥¡¡¼(Assay buffer)¤Ë¤Ä¤¤¤Æ ¥­¥Ã¥È¤ËƱº­¤µ¤ì¤Æ¤¤¤ë¥¢¥Ã¥»¥¤¥Ð¥Ã¥Õ¥¡¡¼¤Ï¡¢ÁÈ¿¥/·ìµå¥µ¥ó¥×¥ë¤ÎÄ´À½¤Ë»ÈÍѤ·¤Þ¤¹¡£
11 È¿±þ²¹Å٤ˤĤ¤¤Æ Q:STEP 6¤Ç60¡î¤Ë¤Æ60ʬ´Ö¥¤¥ó¥­¥å¥Ù¡¼¥È¤È¤¢¤ê¤Þ¤¹¤¬¡¢50¡î¤Ï¤É¤¦¤Ç¤¹¤«¡©
A:50¡î¤Ç¤â¬Äê²Äǽ¤Ç¤¹¤¬¡¢»îÌôÀ­Ç½¤ò½½Ê¬¤Ëȯ´ø¤¹¤ë¤¿¤á¡¢60¡î¤Ç¤ÎÈ¿±þ¤ò¤ª¾©¤á¤·¤Þ¤¹¡£
12 ȯ¿§¤¬Ä㤤¾ì¹ç¤Î¥Á¥§¥Ã¥¯¥Ý¥¤¥ó¥È 1: ¥­¥ã¥ê¥Ö¥ì¡¼¥¿¡¼¤Ï¥Ô¥ó¥¯¿§¤Ëȯ¿§¤·¡¢Ç»ÅÙ¤¬¹â¤¤¥­¥ã¥ê¥Ö¥ì¡¼¥¿¡¼¤Û¤É¥Ô¥ó¥¯¿§¤¬Ç»¤¯¤Ê¤ê¤Þ¤¹¡£ ȯ¿§¤·¤Æ¤¤¤ë¤«¤É¤¦¤«ÌÜ»ë¤Ë¤Æ³Îǧ¤·¤Æ¤¯¤À¤µ¤¤¡£
2: ¥Þ¥¤¥¯¥í¥×¥ì¡¼¥È¥ê¡¼¥À¡¼Åù¤ÇñÇÈŤǬÄꤹ¤ë¾ì¹ç¤Ë¤Ï¡¢Â¬ÄêÇÈĹ¡Ê¥Õ¥£¥ë¥¿¡¼ÇÈĹ¡Ë¤¬ 532nm¤Ç¤¢¤ë¤³¤È¤ò³Îǧ¤·¤Æ¤¯¤À¤µ¤¤¡£
3: TBA»îÌô¤òÄ´À½¤¹¤ëºÝ¡¢¾øα¿å¤Î²¹ÅÙ¤¬Ä㤤¤ÈTBA¤¬´°Á´¤ËÍϤ±¤Æ¤¤¤Ê¤¤¾ì¹ç¤¬¤¢¤ê¤Þ¤¹¡£ TBA¤ÎÍϲò¤¬½½Ê¬¤Ç¤Ê¤¤¤È¡¢µÛ¸÷ÅÙ¤¬Ä㤯¤Ê¤ë¾ì¹ç¤¬¤¢¤ê¤Þ¤¹¡£ ¤Þ¤¿¡¢TBA»îÌô¤ÎÍϲò¤Ë¡¢¥¢¥Ã¥»¥¤¥Ð¥Ã¥Õ¥¡¡¼¤Ï»ÈÍѤǤ­¤Þ¤»¤ó¤Î¤Ç¤´Ãí°Õ¤¯¤À¤µ¤¤¡£
4: È¿±þ±Õ¤òÎäµÑ¤¹¤ë¤ÈÂ࿧¤Î¤¿¤áµÛ¸÷ÅÙ¤¬Ä㤯¤Ê¤ë¾ì¹ç¤¬¤¢¤ê¤Þ¤¹¡£È¿±þ¸å¤Î±Õ¤Ï¡¢Â¬Äê¤Þ¤Ç ¼¼²¹¤Ë¤ÆÊݴɤ·¤Æ¤¯¤À¤µ¤¤¡£
13 µÛ¸÷ÅÙ¬Äê¤Þ¤Ç¤ÎÊÝ´ÉÊýË¡ È¿±þ½ªÎ»¸å¤Î¥µ¥ó¥×¥ë¤ÏÈæ³ÓŪ°ÂÄê¤Ç¤¹¤Î¤Ç¡¢µÛ¸÷Å٤άÄê¤Þ¤Ç¼¼²¹¤Ë¤ÆÊݴɤ·¤Þ¤¹¡£¾°¡¢ÎäµÑ¤¹¤ë¤È Â࿧¤¬µ¯¤­¤ë¾ì¹ç¤¬¤¢¤ê¤Þ¤¹¤Î¤Ç¤´Ãí°Õ¤¯¤À¤µ¤¤¡£
14 ¥µ¥ó¥×¥ë¤Î°ÂÄêÀ­ ¥Þ¥í¥ó¥¸¥¢¥ë¥Ç¥Ò¥É¬Äê¤Î¤¿¤á¤Î¥µ¥ó¥×¥ë¤Ï¡¢-70¡î¤Ç¤ÎÅà·ëÊݸ¤Ë¤Æ1ǯ°Ê¾å°ÂÄê¤Ç¤¹¡£ Åà·ëÍ»²ò¤ÏÈò¤±¤Æ¤¯¤À¤µ¤¤¡£
15 2ÁêʬΥ¤Ë¤è¤ëÂù¤ê½üµî¤Ë¤Ä¤¤¤Æ
¡ÊÀâÌÀ½ñ10¥Ú¡¼¥¸¡Ë
¥Ö¥¿¥Î¡¼¥ë¤È¥¯¥í¥í¥Û¥ë¥à¤Ç¤ÎŬÍÑÎ㤬µ­ºÜ¤µ¤ì¤Æ¤¤¤Þ¤¹¤¬¡¢¥¯¥í¥í¥Û¥ë¥à¤ËÈæ¤Ù¥Ö¥¿¥Î¡¼¥ë¤òÍѤ¤¤¿Êý¤¬ Áê¤Î¶­³¦¤¬ÌÀÎƤǡ¢¤«¤Ä²ó¼ýΨ¤â¹â¤¤¤è¤¦¤Ç¤¹¡£

»é¼Á¤ò¿¤¯´Þ¤à¥µ¥ó¥×¥ëÅù¤Î¾ì¹ç¡¢¥Ö¥¿¥Î¡¼¥ë¤È¥¯¥í¥í¥Û¥ë¥à¤Î¶­³¦¤Ë¡¢ Â礭¤ÊÇò¿§ÁØ¡Ê¥¨¥Þ¥ë¥¸¥ç¥ó¡Ë¤¬·ÁÀ®¤µ¤ì¤ë¤³¤È¤¬¤¢¤ê¤Þ¤¹¡£ ¤³¤Î¤è¤¦¤Ê¥±¡¼¥¹¤Ç¤Ï¡¢Ë°ÏÂNaCl¿åÍϱդò1Å©²Ã¤¨¤ë¤³¤È¤Ç¡¢²þÁ±¤µ¤ì¤ë¤³¤È¤¬¤¢¤ë¤è¤¦¤Ç¤¹¡£
16 ¿©ÉÊ¥µ¥ó¥×¥ë¤Ø¤ÎŬÍѤˤĤ¤¤Æ ²ÃǮĴÍý¤·¤¿¿©ÉʤˤÏMDA¤¬Â¿¤¯´Þ¤Þ¤ì¤Æ¤¤¤ë¤³¤È¤¬ÃΤé¤ì¤Æ¤¤¤Þ¤¹¡£Î㤨¤Ð²ÃǮĴÍý¤·¤¿¥Ï¥ó¥Ð¡¼¥¬¡¼¤Ë¤Ï 1.79¦Ìmol/ 250g¤ÎMDA¤¬´Þ¤Þ¤ì¤Æ¤ª¤ê¡¢¹³»À²½Êª¼Á¤ò´Þ¤à¥¹¥Ñ¥¤¥¹¤òź²Ã¤¹¤ë¤³¤È¤ÇMDA¤ÎÀ¸À®¤¬ÍÞÀ©¤µ¤ì¤ë¤³¤È¤¬Êó¹ð ¤µ¤ì¤Æ¤¤¤Þ¤¹¡£¿©ÉÊ¥µ¥ó¥×¥ë¤Ë¤ÏÔ󻨰ø»Ò¤¬Â¿¤¯´Þ¤Þ¤ì¤Æ¤ª¤ê¡¢¿©ÉÊÃæ¤ÎMDA¬Äê¤Ë¤Ï¡¢Á°½èÍý/Ãê½Ð¤¬É¬ÍפǤ¹¡£
¿©Æù¤Î¾ì¹ç¡¢²¼µ­¤ÎÊýË¡¤Ç¬Äê¤Ç¤­¤ë²ÄǽÀ­¤¬¤¢¤ê¤Þ¤¹¡£¤´¸¡Æ¤¤¯¤À¤µ¤¤¡£
1) ɹÎ䤷¤¿¥¢¥Ã¥»¥¤¥Ð¥Ã¥Õ¥¡¡¼9ÍÆÎ̤ËÂФ·ÁÈ¿¥1ÍÆÎÌ¡¢0.1% BHT¤òź²Ã¤·¡¢¥Û¥â¥¸¥Í¡¼¥È¤òÄ´À½¡£
2) ¥Ø¥â¥°¥í¥Ó¥ó½üµî½èÍý¡Ê¥×¥í¥È¥³¥ë¤Ï¤³¤Á¤é¤ò¤´»²¾È¤¯¤À¤µ¤¤¡Ë
3) MDA¬Äꥭ¥Ã¥È¤Ë¤Æ¬Äê¡Ê¥¹¥Ú¥¯¥È¥ë¬Äê¡Ë
4) ¥¹¥Ú¥¯¥È¥ë¥Ç¡¼¥¿¤ò3rd delivative analysis¤Ë¤Æ²òÀÏ
¤´¼ÁÌä¤Ê¤É¤ªµ¤·Ú¤Ë¤É¤¦¤¾¡Ê¥á¡¼¥ë¡Ë À½ÉʾðÊó¤ËÌá¤ë
¡Ú»²¹Íʸ¸¥¡Û
1) Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes.
Free Radic Biol Med 11(1), p81-128 (1991)
Esterbauer H, Schaur RJ, Zollner H.
2) Biomarkers of free radical damage applications in experimental animals and in humans.
Free Radic Biol Med 26(1-2), p202-226 (1999), de Zwart LL, Meerman JH, Commandeur JN, Vermeulen NP.
3) Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury.
Free Radic Biol Med 9(6),p515-540 (1990), Janero DR.
4) Improved analysis of malondialdehyde in human body fluids.
Free Radic Biol Med 20(2), p251-256 (1996), Jentzsch AM, Bachmann H, Furst P, Biesalski HK.
5) Reactions of 1-methyl-2-phenylindole with malondialdehyde and 4-hydroxyalkenals. Analytical applications to a colorimetric assay of lipid peroxidation.
Chem Res Toxicol.11(10):p1176-1183. (1998), Gerard-Monnier D, Erdelmeier I, Regnard K, Moze-Henry N, Yadan JC, Chaudiere J.
6) Free and bound malondialdehyde measured as thiobarbituric acid adduct by HPLC in serum and plasma.
Clin Chem 37(8),p1423-1429 (1991), Carbonneau MA, Peuchant E, Sess D, Canioni P, Clerc M.
7) Determination of malondialdehyde as dithiobarbituric acid adduct in biological samples by HPLC with fluorescence detection: comparison with ultraviolet-visible spectrophotometry.
Clin Chem 47(9), p1725-1727 (2001), Lykkesfeldt J.
8) Grapefruit seed extract moderates morphologic, functional and biochemical evidences of epidoxorubicin-induced testicular toxicity.
J Med Sci 7(4), p650-654 (2007), LC Saalu, T Kpela, LAJ Shittu, OA Ashiru.
¹³´âºÞ Epidoxorubicin¤ÎÀ¸ÂÎÆÇÀ­¤Ë¤è¤ê¥é¥Ã¥ÈÁÈ¿¥MDA¤¬ÂçÉý¤ËÁý²Ã¤¹¤ë¤³¤È¡¢¥°¥ì¡¼¥×¥Õ¥ë¡¼¥Ä¼ï»ÒÃê½Ðʪ¤¬ÍÞÀ©¸ú²Ì¤ò ¼¨¤¹¤³¤È¤¬Êó¹ð¤µ¤ì¤Æ¤¤¤Þ¤¹¡£âдÝÁÈ¿¥¤òÂоݤË10¡ó¥Û¥â¥¸¥Í¡¼¥È¤òÄ´À½¤·¤Æ¡¢ÁÈ¿¥Ãæ¤ÎMDAÇ»ÅÙ¤ò¬Äê¡£Âоȷ²¡Ê0.78¡Þ0.07 nmol/mL¡Ë¤Ë ÂФ·¡¢EpidoxorubicinÅêÍ¿·²¡Ê1.63¡Þ0.24 nmol/L¡Ë¤ÈÍ­°Õ¤Ë¹âÃͤò¼¨¤·¤Þ¤¹¡£Epidoxorubicin + ¥°¥ì¡¼¥×¥Õ¥ë¡¼¥Ä¼ï»ÒÃê½ÐʪÅêÍ¿·²¤Ç¤Ï MDAÁý²Ã¤¬Í­°Õ¤ËÍÞÀ©¤µ¤ì¤Æ¤¤¤Þ¤¹¡Ê0.88¡Þ0.09 nmol/L¡Ë¡£
9) Sildenafil extends survival and graft function in a large animal lung transplantation model. Eur J Cardio-thoracic Surg 29, p288-293 (2006) Stephan Korom, Sven Hillinger, Markus Cardell, Wei Zhai, Qiang Tan,Andre Dutly, Boris Leskosek, Walter Weder
¥Ö¥¿¤ò»È¤Ã¤¿ÇÙ°Ü¿¢»î¸³¡£Àµ¾ï¤Ê¥Ö¥¿ÇÙÁÈ¿¥¤Ë¤ª¤±¤ëMDAÇ»ÅÙ¡Ê12.4¡Þ0.9¦ÌM¡Ë¤ËÂФ·¡¢°Ü¿¢¸å¤ÎÇÙÁÈ¿¥Ãæ¤ÎMDAÇ»ÅÙ ¡Ê18.5¡Þ3.0¦ÌM¡Ë¤ÏÍ­°Õ¤Ë¹âÃͤò¼¨¤·¤Þ¤¹¡£Sildenafil¡Ê¥Û¥¹¥Û¥¸¥¨¥¹¥Æ¥é¡¼¥¼-5Á˳²ºÞ¡Ë¤Î»öÁ°ÅêÍ¿¤Ë¤è¤ê°Ü¿¢¸å¤ÎÀ¸Â¸´ü´Ö¤Î±äĹ¡¢ °Ü¿¢Ç٤ε¡Ç½±äŸú²Ì¤¬Ç§¤á¤é¤ì¡¢°Ü¿¢ÇÙ¤ÎMDAÇ»ÅÙ¡Ê13.8¡Þ1.6¦ÌM¡Ë¤âÍ­°Õ¤ËÍÞÀ©¤µ¤ì¤ë¤³¤È¤¬Êó¹ð¤µ¤ì¤Æ¤¤¤Þ¤¹¡£
10) Increased oxidative damage in peripheral blood correlates with severity of Parkinson's disease. Neurobiol Dis. 2008 Dec 9.¡¡(in press) Chen CM, Liu JL, Wu YR, Chen YC, Cheng HS, Cheng ML, Chiu DT.
¥Ñ¡¼¥­¥ó¥½¥óÉ´µ¼Ô¤Î·ìÞùMDAÇ»Å٤Ϸò¾ïÂоȤËÈæ¤Ù¹âÃͤò¼¨¤·¤Þ¤¹¡£
11) Oxidative stress in small-for-gestational age (SGA) term newborns and their mothers. Free Radical Research 43(4) , p376-384 (2009)
Snjezana Gveric-Ahmetasevic, Suzana Borovic Sunjic, Hana Skala, Luka Andrisic, Marina Stroser, Kamelija Zarkovic, Snjezana Skrablin, Franz Tatzber, Ana Cipak, Morana Jaganjac, Georg Waeg, Tugomir Gveric, Neven Zarkovic
½Ð»º»þ¤Ë¤ª¤±¤ë»À²½¥¹¥È¥ì¥¹¸¦µæÎã¤Ç¤¹¡£SGA¡Êsmall-for-gestational age:»ÒµÜÆâȯ°éÉÔÁ´·²¡Ë47̾¡¢ AGA¡Êappropriate-for-gestational age: Àµ¾ïȯ°é·²¡Ë67̾¤ª¤è¤ÓÇ¥¿±¤·¤Æ¤¤¤Ê¤¤·ò¾ï½÷À­29̾¤òÂоݤ˻À²½¥¹¥È¥ì¥¹¤òɾ²Á¡£ AGA·²¤ËÈæ¤ÙSGA·²¤Ç¤ÏÊì»Ò¤È¤â¤ËʬÊÚ»þ¤Î·ìÀ¶MDA¤¬¹âÃͤò¼¨¤¹¤³¤È¡¢·ìÀ¶MDAÇ»ÅÙ¤ÏçÁÂÓÆ°Ì®·ì¤è¤ê¤âçÁÂÓÀÅÌ®·ì¤ÎÊý¤¬¹âÃͤò¼¨¤¹¤³¤È¤¬ ¸«½Ð¤µ¤ì¤Æ¤¤¤Þ¤¹¡£Êì¿Æ¤Î·ìÀ¶¹³»À²½Ç½¤ÏAGA·²¡¢SGA·²¤È¤â¤ËÂоȷ²¤ËÈæ¤ÙÄãÃͤǤ¢¤ê¡¢½Ð»º»þ¤Ë»À²½¥¹¥È¥ì¥¹¤¬Ð¶¿Ê¤¹¤ë¤³¤È¤ò¼¨¤·¤Æ¤¤¤Þ¤¹ ¡Ê¾°¡¢MDA¬Äê¤Ë¤ÏHPLCË¡¤òÍѤ¤¤Æ¤¤¤Þ¤¹¡Ë¡£
12) Malondialdehyde in exhaled breath condensate and urine as a biomarker of air pollution induced oxidative stress. J Expo Sci Environ Epidemiol 23,p322-327 (2013)
Jicheng Gong, Tong Zhu, Howard Kipen, Guangfa Wang, Min Hu, Pamela Ohman-Strickland, Shou-En Lu, Lin Zhang, Yuedan Wang, Ping Zhu, David Q Rich, Scott R Diehl, Wei Huang and Junfeng (Jim) Zhang
Â絤±øÀ÷¤Ë¤è¤ë·ò¹¯Èï³²¤Î¥á¥«¥Ë¥º¥à¤Ë¤Ï¡¢»À²½¥¹¥È¥ì¥¹¤¬´Ø¤ï¤Ã¤Æ¤¤¤ë²ÄǽÀ­¤¬¼¨º¶¤µ¤ì¤Æ¤¤¤ë¡£ ËÜʸ¸¥¤Ç¤Ï¡¢Ë̵þ¥ª¥ê¥ó¥Ô¥Ã¥¯¤Î³«ºÅ´ü´Ö¡ÊÁ°/´ü´ÖÃæ/¸å¡Ë¤Ë¤ª¤±¤ë¸Æµ¤Ç»½Ì±Õ¤ª¤è¤ÓÇ¢Ãæ¥Þ¥í¥ó¥¸¥¢¥ë¥Ç¥Ò¥É¤ò¬Äê¡£ Â絤±øÀ÷¤ÎÄøÅ٤ȡ¢¾åµ­»îÎÁÃæ¤Î¥Þ¥í¥ó¥¸¥¢¥ë¥Ç¥Ò¥ÉÇ»ÅÙ¤¬Âбþ´Ø·¸¤Ë¤¢¤ê¡¢Â絤±øÀ÷¤ÎÀ¸ÂαƶÁ¤Î¥Ð¥¤¥ª¥Þ¡¼¥«¡¼¤È¤·¤Æ Í­ÍѤǤ¢¤ë¤³¤È¤ò¼¨º¶¤·¤Æ¤¤¤ë¡£
¤´¼ÁÌä¤Ê¤É¤ªµ¤·Ú¤Ë¤É¤¦¤¾¡Ê¥á¡¼¥ë¡Ë À½ÉʾðÊó¤ËÌá¤ë
SOD³èÀ­Â¬Äꥭ¥Ã¥È¡ÊÈ濧ˡ¡Ë
No. ¡Ú¥¿¥¤¥È¥ë¡Û ¡ÚÆâÍÆ¡Û
1 Q¡§¿¢ÊªÃê½Ð±Õ¤ò¬Äê¤Ç¤­¤Þ¤¹¤«¡© A¡§Ãê½Ð±ÕÃæ¤ËSOD¤¬Â¸ºß¤¹¤ì¤Ð¬Äê¤Ç¤­¤ë²ÄǽÀ­¤¬¤¢¤ê¤Þ¤¹¡£Â¬ÄêÇÈĹ¡Ê560nm¡Ë¤Ë¶¯¤¤µÛ¼ý¤¬ ¤Ê¤¤¤«¤´Ãí°Õ¤¯¤À¤µ¤¤¡£
2 Q¡§Ê¬¸÷¸÷ÅٷפǬÄê¤Ç¤­¤Þ¤¹¤«¡© A¡§Â¬Äê²Äǽ¤Ç¤¹¡£Î㤨¤Ðʬ¸÷¸÷ÅٷפΥ­¥å¥Ù¥Ã¥ÈÍÆÎ̤¬1mL¤Î¾ì¹ç¡¢¥¢¥Ã¥»¥¤¥Ð¥Ã¥Õ¥¡¡¼920¦ÌL¡¢ ¥µ¥ó¥×¥ë40¦ÌL¡¢¥Ø¥Þ¥È¥­¥·¥ê¥ó»îÌô40¦ÌL¤Î¤è¤¦¤Ë»îÌô¤È¥µ¥ó¥×¥ëÎ̤ò4Çܤˤ¹¤ë¤³¤È¤Ç¬Äê¤Ç¤­¤Þ¤¹¡£ ¥­¥å¥Ù¥Ã¥ÈÍÆÎÌ1mL¤Î¾ì¹ç¡¢¥Æ¥¹¥È¿ô¤Ï30Á°¸å¤Ë¤Ê¤ë¤³¤È¤Ë¤´Ãí°Õ¤¯¤À¤µ¤¤¡£
3 ÁÈ¿¥¥Û¥â¥¸¥Í¡¼¥È¤ÎÄ´À½Ë¡¤È
¥µ¥ó¥×¥ëÊݸÊýË¡
ÊݸÊýË¡
ÁÈ¿¥¥Û¥â¥¸¥Í¡¼¥È¤ò¬Äꤹ¤ë¾ì¹ç¡¢Ç˺ÕÁ°¤ÎÁÈ¿¥¤Ï-70¡î°Ê²¼¤Ë¤ÆÊݸ¤·¡¢¥Û¥â¥¸¥Í¡¼¥È Ä´À°¸å¤ÏÅöÆüÃæ¤Ë¬Äꤷ¤Æ¤¯¤À¤µ¤¤¡£ÇÝÍܺÙ˦¤Î¾ì¹ç¡¢ºÙ˦¥Ú¥ì¥Ã¥È¤Î¾õÂÖ¤Ç-70¡î°Ê²¼¤Ë¤ÆÊݸ¤·¡¢Â¬ÄêÅöÆü¤Ë ¥Û¥â¥¸¥Ê¥¤¥º¤ä¥½¥Ë¥±¡¼¥·¥ç¥ó¤ò¼Â»Ü¤¹¤ë¤³¤È¤ò¤ª¾©¤á¤·¤Þ¤¹¡£

Þõή
ÀÖ·ìµåͳÍèSOD¤Î±Æ¶Á¤ò¼è¤ê½ü¤¯¾ì¹ç¤Ë¤Ï¡¢Þõή¤Ë¤è¤ê·ì±Õ¤ò½üµî¤·¤Æ¤ª¤­¤Þ¤¹¡£
»ÈÍѤ¹¤ëÞõή±Õ¤ÎÎ㡧0.16 mg/mL Heparin¤ò´Þ¤àÀ¸Íý¿©±ö¿å¡£

¥Û¥â¥¸¥Í¡¼¥ÈÄ´À½Îã
ÁÈ¿¥ 1ÍÆÎ̤ËÂФ·9ÍÆÎ̤ÎPBS(pH7.4)¤òź²Ã¤·¤ÆÇ˺յ¡¤ò»È¤Ã¤Æ¥Û¥â¥¸¥Í¡¼¥È¤òÄ´À½¡£ ±ó¿´¾åÀ¶¡ÊÎ㡧1000rpm * 10min, 4¡î¡Ë¤òSOD¬Äꥭ¥Ã¥È¤ËŬÍÑ¡£
»²¹Íʸ¸¥¡§Tomasz Brzozowski, et. al.,Therapeutic potential of 1-methylnicotinamide against acute gastric lesions induced by stress. Role of endogenous prostacyclin and sensory nerves. J Pharmacol Exp Ther (2008)
Hong Wei Yao, et. al., Losartan Attenuates Bleomycin-Induced Pulmonary Fibrosis in Rats. Respiration 73(2)236-42(2006)
4 ưʪÁÈ¿¥¤Ø¤ÎŬÍÑ»öÎã ¥Þ¥¦¥¹ Ǿ¡Ê¥Û¥â¥¸¥Í¡¼¥È¾åÀ¶¡Ë:30¡Á40 U/mg brain tissue
Anekonda TS¤é¡§J Alzheimers Dis.23(1), p21-35(2011).
5 Q¡§¥¿¥¤¥à¥³¡¼¥¹¤¬Ä¾Àþ¤Ë¤Ê¤é¤Ê¤¤¾ì¹ç¤ÎÂнèË¡ A¡§¥µ¥ó¥×¥ëÃæ¤Ë¥Ø¥Þ¥È¥­¥·¥ê¥ó¼«Æ°»À²½¤òÍÞÀ©¤¹¤ëÀ®Ê¬¤¬´Þ¤Þ¤ì¤Æ¤¤¤ë¤È¥¿¥¤¥à¥³¡¼¥¹¤¬ÏѶʤ¹¤ë ¾ì¹ç¤¬¤¢¤ê¤Þ¤¹¡£Ëؤɤξì¹ç¡¢È¿±þ³«»Ï¸å10ʬ°ÊÆâ¤ÏľÀþŪ¤ËµÛ¸÷ÅÙ¤¬¾å¾º¤·¤Þ¤¹¤Î¤Ç¡¢10ʬ°ÊÆâ¤ÎľÀþÉôʬ¤òÍøÍѤ·¤Æ ¬Äꤹ¤ë¤³¤È¤Ç¡¢Ôó»¨Êª¼Á¤Î±Æ¶Á¤ò²óÈò¤¹¤ë¤³¤È¤¬¤Ç¤­¤Þ¤¹¡£¤³¤Î¤Û¤«¡¢¥¢¥Ã¥»¥¤¥Ð¥Ã¥Õ¥¡¤Ë¤è¤ë´õ¼á¤ä¡¢Æ©ÀÏÅù¤ò¼Â»Ü¤¹¤ë ¤³¤È¤Ç²þÁ±¤µ¤ì¤ë¾ì¹ç¤¬¤¢¤ê¤Þ¤¹¡£
6 ¥Ò¥È·ìÀ¶¥µ¥ó¥×¥ë¤Ø¤ÎŬÍÑ SOD¤Î¿¤¯¤ÏºÙ˦Æâ¤ËʬÉÛ¤·¤Æ¤ª¤ê¡¢·ìÀ¶Ãæ¤ÎSOD³èÀ­¤Ï¸¡½Ð¸Â³¦°Ê²¼¤È¤Ê¤ë¾ì¹ç¤¬¤¢¤ê¤Þ¤¹¡£ ·ìÀ¶¥µ¥ó¥×¥ë¤Ï-70¡î¤Ë¤ÆÅà·ëÊݸ¤·¤Æ¤¯¤À¤µ¤¤¡£
7 ¥¢¥Ã¥»¥¤¥Ð¥Ã¥Õ¥¡¡¼¤ÎÀϽРÊݸ¾ò·ï¤Ë¤è¤ê¡¢µ©¤Ë¥¢¥Ã¥»¥¤¥Ð¥Ã¥Õ¥¡¡¼¤Ë·ë¾½¤ÎÀϽФ¬¸«¤é¤ì¤ë¤³¤È¤¬¤¢¤ê¤Þ¤¹¡£
¤³¤Î¾ì¹ç¤Ë¤Ï¡¢¥¢¥Ã¥»¥¤¥Ð¥Ã¥Õ¥¡¡¼¤ò·Ú¤¯²¹¤á¤Æ´°Á´¤ËÍϲò¤·¤Æ¤«¤é»ÈÍѤ·¤Æ¤¯¤À¤µ¤¤¡£
8 ¼õÂ÷¸¡ºº¤Ë¤Ä¤¤¤Æ SOD³èÀ­¤Ë¤Ä¤­¤Þ¤·¤Æ¤Ï¡¢¼õÂ÷¸¡ºº¤â¼Â»Ü²Äǽ¤Ç¤¹¡£ ÂоݤϷìÀ¶¡¢·ìÞù¡¢ÁÈ¿¥¤Ç¤¹¡£
¤´¼ÁÌä¤Ê¤É¤ªµ¤·Ú¤Ë¤É¤¦¤¾¡Ê¥á¡¼¥ë¡Ë À½ÉʾðÊó¤ËÌá¤ë
¡Ú»²¹Íʸ¸¥¡Û
1) Methods of detection of vascular reactive species: nitric oxide, superoxide, hydrogen peroxide, and peroxynitrite. Circ Res. 89(3),p224-236(2001), Tarpey MM and Fridovich I.
2) Negative and positive assays of superoxide dismutase based on hematoxylin autoxidation. Arch Biochem Biophys. 255(2), p329-336.(1987), Martin JP Jr, Dailey M, Sugarman E.
3) Vascular extracellular superoxide dismutase activity in patients with coronary artery disease: relation to endothelium-dependent vasodilation. Circulation. 101(19),p2264-2270 (2000), Landmesser U, Merten R, Spiekermann S, Buttner K, Drexler H, Hornig B.
4) Phytic acid as a potential treatment for alzheimer's pathology: evidence from animal and in vitro models. J Alzheimers Dis 23(1),p21-35(2011). Anekonda TS, Wadsworth TL, Sabin R, Frahler K, Harris C, Petriko B, Ralle M, Woltjer R, Quinn JF.
¥Þ¥¦¥¹Ç¾¡Êfrontal cortex tissue¡Ë¤Ø¤ÎŬÍÑÎã¤Ç¤¹¡£
¤´¼ÁÌä¤Ê¤É¤ªµ¤·Ú¤Ë¤É¤¦¤¾¡Ê¥á¡¼¥ë¡Ë À½ÉʾðÊó¤ËÌá¤ë
¥Ò¥ÈCu/Zn-SOD¬ÄêÍÑELISA¥­¥Ã¥È
No. ¡Ú¥¿¥¤¥È¥ë¡Û ¡ÚÆâÍÆ¡Û
1 ¥Ò¥È·ìÀ¶Â¬ÄêÎã ·ò¾ï¼Ô·ìÀ¶22̾¤òÂоݤˤ·¤¿Â¬Äê¤Ç¡¢22.5¡Á102.9 ng/mL¡ÊÊ¿¶ÑÃÍ 56.5 ng/mL¡Ë¤È¤Î·ë²Ì¤¬ÆÀ¤é¤ì¤Æ¤¤¤Þ¤¹¡£
2 ÀÖ·ìµå¤Ç¤Î¬ÄêÎã çÁÂÓ·ìÀÅÌ®¤«¤éºÎ¼è¤·¤¿ÀÖ·ìµå¤Ç¤Ï 11¡Á16 ng/106 ÀÖ·ìµå¡¢¥À¥¦¥ó¾É¸õ·²¤Ç¤Ï ¡ä20ng/106ÀÖ·ìµå ¤ò¼¨¤¹¤³¤È¤¬Êó¹ð¤µ¤ì¤Æ¤¤¤Þ¤¹¡£
3 ·ìÀ¶¤È·ìÞù¤Ç¤Îº¹°Û¤Ë¤Ä¤¤¤Æ ·ò¾ï¼Ô22̾¤òÂоݤˡ¢·ìÀ¶¡¢¥¯¥¨¥ó»À·ìÞù¡¢EDTA·ìÞù¡¢¥Ø¥Ñ¥ê¥ó·ìÞù¤òºÎ¼è¤·¡¢ELISA¥­¥Ã¥È¤Ë¤Æ ¬Äꤷ¤¿·ë²Ì¡¢¥µ¥ó¥×¥ë¤Î¼ïÎà¤Ë¤è¤ë¬ÄêÃͤËÍ­°Õº¹¤Ï¸«¤é¤ì¤Þ¤»¤ó¤Ç¤·¤¿¡£
4 Åà·ëÍ»²ò¤Î±Æ¶Á¤Ë¤Ä¤¤¤Æ ·ìÀ¶¥µ¥ó¥×¥ë¤Î¾ì¹ç¡¢5²ó¤Þ¤ÇÅà·ëÍ»²ò¤ò·«¤êÊÖ¤·¤Æ¤â¡¢Â¬ÄêÃͤËÊѲ½¤Ïǧ¤á¤é¤ì¤Þ¤»¤ó¤Ç¤·¤¿¡£
5 »îÌô¹½À®¤ÎÊѹ¹¤Ë¤Ä¤¤¤Æ TMB´ð¼Á±Õ¤¬¡¢½¾Íè¤Î£²±Õº®¹ç¥¿¥¤¥×¤«¤é£±±Õ¥¿¥¤¥×¤Ë²þÁ±¤µ¤ì¡¢¤è¤ê»È¤¤°×¤¯¤Ê¤ê¤Þ¤·¤¿¡Ê2008ǯ9·î¡Ë¡£
¤´¼ÁÌä¤Ê¤É¤ªµ¤·Ú¤Ë¤É¤¦¤¾¡Ê¥á¡¼¥ë¡Ë À½ÉʾðÊó¤ËÌá¤ë
¡Ú»²¹Íʸ¸¥¡Û
1) The complete amino acid sequence of human Cu/Zn superoxide dismutase. Barra D, Martini F, Bannister JV, Schinina ME, Rotilio G, Bannister WH, Bossa F., FEBS Lett. 120(1), p53-56 (1980)
2) Subunit structure of human superoxide dismutase. Hartz JW, Deutsch HF., J Biol Chem. 247(21), p7043-7050 (1972)
3) Redox-activated expression of the cytosolic copper/zinc superoxide dismutase gene in Nicotiana.
Herouart D, Van Montagu M, Inze D., PNAS 90(7), p3108-3112 (1993)
4) Age-dependent basal level and induction capacity of copper-zinc and manganese superoxide dismutase and other scavenging enzyme activities in leukocytes from young and elderly adults. Niwa Y, Iizawa O, Ishimoto K, Akamatsu H, Kanoh T., Am J Pathol. 143(1), p312-320.(1993)
5) A rapid and sensitive enzyme immunoassay for Cu/Zn superoxide dismutase with polyclonal and monoclonal antibodies. Porstmann T, Wietschke R, Schmechta H, Grunow R, Porstmann B, Bleiber R, Pergande M, Stachat S, von Baehr R., Clin Chim Acta. 171(1):p1-10 (1988)
6) Immunochemical quantification of Cu/Zn superoxide dismutase in prenatal diagnosis of Down's syndrome. Porstmann T, Wietschke R, Cobet G, Lorenz K, Grunow R, Jahn S, Bollmann R, Stamminger G, von Baehr R. Hum Genet. 85(3), p362-366 (1990)
7) Cu/Zn superoxide dismutase quantification from fetal erythrocytes--an efficient confirmatory test for Down's syndrome after maternal serum screening and sonographic investigations. Porstmann T, Wietschke R, Cobet G, Stamminger G, Bollmann R, Rogalski V, Pas P., Prenat Diagn. 11(5), p295-303 (1991)
8) Differential regulation of antioxidant enzymes in response to oxidants. Shull S, Heintz NH, Periasamy M, Manohar M, Janssen YM, Marsh JP, Mossman BT., J Biol Chem. 266(36), p24398-24403 (1991)
9) Superoxide dismutase is regulated by LAMMER kinase in Drosophila and human cells.
Brian P. James, William D. Staatz, Sarah T. Wilkinson, Emmanuelle Meuillet and Garth Powis
Free Radical Biology and Medicine 46(6), p821-827(2009)
SOD1(Cu/Zn-SOD)¤ÏLAMMER¥­¥Ê¡¼¥¼ (CDC-2-like ¥­¥Ê¡¼¥¼/ CLK¥­¥Ê¡¼¥¼)¤Ë¤è¤êÀ©¸æ¤µ¤ì¤Æ¤¤¤ë¤³¤È¡¢ ¤³¤ÎLAMMER¥­¥Ê¡¼¥¼¤Ë¤è¤ëSOD1¤ÎÀ©¸æ¤Ï¹ÚÊ줫¤é¥Ò¥È¤Þ¤Ç¿Ê²½Åª¤ËÊݸ¤µ¤ì¤Æ¤¤¤ë¤³¤È¤¬¼¨º¶¤µ¤ì¤Æ¤¤¤Þ¤¹¡£
¤´¼ÁÌä¤Ê¤É¤ªµ¤·Ú¤Ë¤É¤¦¤¾¡Ê¥á¡¼¥ë¡Ë À½ÉʾðÊó¤ËÌá¤ë
¥°¥ë¥¿¥Á¥ª¥ó¬Äꥭ¥Ã¥È
No. ¡Ú¥¿¥¤¥È¥ë¡Û ¡ÚÆâÍÆ¡Û
1 ʬ¸÷¸÷ÅٷפǤâ»ÈÍѤǤ­¤Þ¤¹¤«¡© ʬ¸÷¸÷ÅٷפΥ­¥å¥Ù¥Ã¥È¤Ç¤â¬Äê²Äǽ¤Ç¤¹¡£¾ÜºÙ¤Ë¤Ä¤­¤Þ¤·¤Æ¤Ï ¤³¤Á¤é(PDF 137KB)¤ò¤´Í÷¤¯¤À¤µ¤¤¡£
2 96·ê¥Þ¥¤¥¯¥í¥×¥ì¡¼¥È¤Ë¤Ä¤¤¤Æ ËÜ¥­¥Ã¥È¤Ë¤Ï96·ê¥Þ¥¤¥¯¥í¥×¥ì¡¼¥È¤Ï´Þ¤Þ¤ì¤Æ¤ª¤ê¤Þ¤»¤ó¡£Ê¿Ä쥿¥¤¥×¤ÎÆ©ÌÀ¤Ê¥Þ¥¤¥¯¥í¥×¥ì¡¼¥È¤ò ÊÌÅÓ¤´ÍÑ°Õ¤¯¤À¤µ¤¤¡£´ðËÜŪ¤Ë¤É¤Î¥á¡¼¥«¡¼¤Î¤â¤Î¤Ç¤âŬÍѲÄǽ¤È¹Í¤¨¤é¤ì¤Þ¤¹¡£ ¾°¡¢¥í¥Ã¥È¤Ë¤è¤ê¥µ¡¼¥Ó¥¹¤Ç¥Þ¥¤¥¯¥í¥×¥ì¡¼¥È¤¬Æ±º­¤µ¤ì¤Æ¤¤¤ë¾ì¹ç¤â¤¢¤ê¤Þ¤¹¡£
3 4-VP»îÌô¤Ë¤Ä¤¤¤Æ ¥µ¥ó¥×¥ë¤ò4-VP (4-vinylpirydine)¤Ç½èÍý¤¹¤ë¤³¤È¤Ë¤è¤ê¡¢»À²½·¿¥°¥ë¥¿¥Á¥ª¥ó(GSSG)¤ò¬Äꤹ¤ë¤³¤È¤¬ ²Äǽ¤Ç¤¹¡£4-VP¤Ï¥­¥Ã¥È¤Ë¤Ï´Þ¤Þ¤ì¤Æ¤ª¤ê¤Þ¤»¤ó¤Î¤Ç¡¢ÊÌÅÓ¤´ÍÑ°Õ¤¯¤À¤µ¤¤¡ÊÎ㡧 Sigma-Aldrich code.V3204¡Ë¡£ 4-VP¤Ï±ÕÂΤÇÈÎÇ䤵¤ì¤Æ¤ª¤ê¡¢É¹Îä²¼¤Ë¤Æ4-VP 100¦ÌL¤È¥á¥¿¥Î¡¼¥ëËô¤Ï¥¨¥¿¥Î¡¼¥ë 1000¦ÌL¤òº®¹ç¤·¤Æ¤«¤é»ÈÍѤ·¤Þ¤¹¡£ »ÔÈÎ4-VP¤ÎÇ»ÅÙ¤ÏÌó8.8 mol/L¤Ç¤¢¤ê¡¢Ä´À½¸å¤ÎÇ»ÅÙ¤Ï0.8 mol/L¤È¤Ê¤ê¤Þ¤¹¡£ËÜ¥×¥í¥È¥³¥ë¤Ç¤Ï4-VP¤ò²á¾ê¤Ëź²Ã¤¹¤ë ·Á¤Ë¤Ê¤Ã¤Æ¤¤¤ë¤¿¤á¡¢4-VP¤ÎÇ»ÅÙ¤Ï0.8¡Á1.0 mol/L¤ÎÈϰϤˤ¢¤ì¤Ðº¹¤·»Ù¤¨¤¢¤ê¤Þ¤»¤ó¡£ ¾ÜºÙ¤Ë¤Ä¤­¤Þ¤·¤Æ¤Ï¡¢GSSG¬Äê¥×¥í¥È¥³¥ë¡Ê±ÑʸPDF¡Ë¤ò ¤´»²¾È¤¯¤À¤µ¤¤¡£
4 ·ìÀ¶¥µ¥ó¥×¥ë¤Ø¤ÎŬÍѤˤĤ¤¤Æ ËÜ¥­¥Ã¥È¤Ï¡¢·ìÀ¶¡¢·ìÞù¤È¤â¤Ë¬Äê²Äǽ¤Ç¤¹¤¬¡¢·ìÀ¶¤è¤ê¤â·ìÞù¤ÎºÎ¼è¤ò¤ª¾©¤á¤·¤Þ¤¹¡£ Íýͳ¤È¤·¤Æ¡¢·ìÀ¶¡¿·ìÞùÃæ¤Î¥°¥ë¥¿¥Á¥ª¥óÇ»ÅÙ¤¬Ä㤤¤Î¤ËÂФ·¡¢ÀÖ·ìµåÃæ¤Ë¤Ï¿Î̤Υ°¥ë¥¿¥Á¥ª¥ó¤¬´Þ¤Þ¤ì¤Æ¤ª¤ê¡¢ ÍϷ줬µ¯¤­¤ë¤È·ìÀ¶¡¿·ìÞùÃæ¤Î¥°¥ë¥¿¥Á¥ª¥óÇ»ÅÙ¤¬Â礭¤¯¾å¾º¤¹¤ë²ÄǽÀ­¤¬¤¢¤ë¤³¤È¤¬µó¤²¤é¤ì¤Þ¤¹¡£
5 ¥µ¥ó¥×¥ë¤ÎÊݸÊýË¡ ¥°¥ë¥¿¥Á¥ª¥ó¤ÏÈæ³ÓŪÎô²½¡Ê»À²½¡Ë¤·¤ä¤¹¤¤¤¿¤á¡¢¥µ¥ó¥×¥ëºÎ¼è¸å¤Ïľ¤Á¤Ë¬Äꤹ¤ë¤³¤È¤¬ ÍýÁۤǤ¹¡£Êݸ¤¹¤ë¾ì¹ç¤Ë¤Ï¡¢Ä¾¤Á¤Ë-20¡î°Ê²¼¤ËÅà·ë¤¹¤ë¤³¤È¤ò¤ª¾©¤á¤·¤Þ¤¹¡£¥µ¥ó¥×¥ë¤Î¼ïÎà¤Ë¤è¤ê 4¡î¡Á¼¼²¹¤ÇµÞ®¤ËGSH¥ì¥Ù¥ë¤¬Äã²¼¤¹¤ë¤³¤È¤¬Êó¹ð¤µ¤ì¤Æ¤¤¤Þ¤¹¡£
¡Ú»²¹Íʸ¸¥¡Û¡§
Beier J, Beeh KM, Kornmann O, Buhl R :Stability of glutathione in induced sputum: impact of freezing.
Respiration 70(5),p523-527(2003): DOI: 10.1159/000074211
6 5¡ó MPA¿åÍϱդÎÄ´À½ MPA¤Ï³Æ¼Ò¤è¤êÈÎÇ䤵¤ì¤Æ¤ª¤ê¤Þ¤¹¤¬¡¢Sigma-Aldrich¼Ò ÉÊÈÖ23975¤Ï ¥Õ¥ì¡¼¥¯¾õ¤Î·ë¾½¤È¤Ê¤Ã¤Æ¤ª¤ê¡¢¼è°·¤¤¤¬ÍưפǤ¹¡£·ë¾½1g¡Ê½ãÅÙ¤Ï35¡óÄøÅ١ˤò19mL¤Î¾øα¿å¤ËÍϲò¤·¤Æ 5¡ó(Weight/Weight)¿åÍϱդòÄ´À½¤·¤Þ¤¹¡£Ä´À½¸å¤ÏÊݸ¤Ç¤­¤Þ¤»¤ó¤Î¤Ç¡¢É¬¤º»ÈÍÑÅöÆü¤ËÍϲò¤·¤Æ¤¯¤À¤µ¤¤¡£
¤´¼ÁÌä¤Ê¤É¤ªµ¤·Ú¤Ë¤É¤¦¤¾¡Ê¥á¡¼¥ë¡Ë À½ÉʾðÊó¤ËÌá¤ë
¡Ú»²¹Íʸ¸¥¡Û
1) Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem. 27(3), p502-522 (1969) Tietze F
2) 241 strategies to improve glutathione content of in vitro-matured bovine oocytes. Reproduction, Fertility and Development 20(1) p200 (2008), E. C. Curnow, J. Ryan, D. Saunders and E. S. Hayes
3) Red wine consumption increases antioxidant status and decreases oxidative stress in the circulation of both young and old humans. Nutrition Journal September 6(27), 2007, Micallef, M; Lexis, L and Lewandowski, P
4) Atrial glutathione content, calcium current and contractility. J. Biol. Chem. 282(38), p28063-28073 (2007), Cynthia A. Carnes, Paul M.L. Janssen, Mary L. Ruehr, Hitomi Nakayama, Tomohiro Nakayama, Hannelore Haase, John Anthony Bauer, Mina K. Chung, Ian M. Fearon, A. Marc Gillinov, Robert L. Hamlin, and David R. Van Wagoner
5) Neuroprotective Effects of 17s-Estradiol and Nonfeminizing Estrogens against H2O2 Toxicity in Human Neuroblastoma SK-N-SH Cells. Mol. Pharmacol. 70, p395-404 (2006) Wang, X; Dykens, JA; Perez, E; Liu, R; Yang, S; Covey, DF; Simpkins, JW
6) The metal-responsive transcription factor-1 contributes to HIF-1 activation during hypoxic stress. Biochem Biophys Res Commun 337(3), p860-867 (2005) Brian J. Murphy, Barbara G. Sato, Timothy P. Dalton and Keith R. Laderoute
7) Effect of dietary cadmium and/or lead on histopathological changes in the kidneys and liver of bank voles Myodes glareolus kept in different group densities.
Ecotoxicology 21(8),p2235-2243(2012), doi: 10.1007/s10646-012-0979-z
Aneta Salinska, Tadeusz Wlostowski and Elzbieta Zambrzycka
ËÜ¥­¥Ã¥È¤Ë¤è¤ë¿ÕÁÈ¿¥Ãæ¤Î¥°¥ë¥¿¥Á¥ª¥ó¬ÄêÎã¤Ç¤¹
¤´¼ÁÌä¤Ê¤É¤ªµ¤·Ú¤Ë¤É¤¦¤¾¡Ê¥á¡¼¥ë¡Ë À½ÉʾðÊó¤ËÌá¤ë
¥°¥ë¥¿¥Á¥ª¥ó¥Ú¥ë¥ª¥­¥·¥À¡¼¥¼(GPx)¬Äꥭ¥Ã¥È
No. ¡Ú¥¿¥¤¥È¥ë¡Û ¡ÚÆâÍÆ¡Û
1 ʬ¸÷¸÷ÅٷפǤâ»ÈÍѤǤ­¤Þ¤¹¤«¡© ʬ¸÷¸÷ÅٷפΥ­¥å¥Ù¥Ã¥È¤Ç¤â¬Äê²Äǽ¤Ç¤¹¡£¥Þ¥¤¥¯¥í¥×¥ì¡¼¥È»ÈÍÑ»þ¤ËÈæ¤Ù¡¢¤è¤êÄãÃͤޤǬÄê¤Ç¤­¤ë¾ì¹ç¤¬ ¤¢¤ê¤Þ¤¹¡Ê1mU/mL¡Ë¡£¥­¥å¥Ù¥Ã¥È¤ÎÍÆÀѤˤè¤ê¥Æ¥¹¥È¿ô¡¢¥µ¥ó¥×¥ë±ÕÎ̤¬ÊѤï¤ê¤Þ¤¹¤Î¤Ç¤´Ãí°Õ¤¯¤À¤µ¤¤¡£
2 GPx¹ÚÁdzèÀ­¤ÎÄêµÁ ËÜ¥­¥Ã¥È¤Ç¤ÏGPx 1 unit¤È¤ÏH2O2¤Î¸ºß²¼¡¢25¡î pH7.0¤Î¾ò·ï²¼¤Ë¤ª¤¤¤Æ 1ʬ´Ö¤Ç1.0¦Ìmole¤ÎGSH¤òGSSG¤Ë»À²½¤¹¤ëÎ̤Ȥ·¤ÆÄêµÁ¤·¤Æ¤¤¤Þ¤¹¡£¤³¤ÎÄêµÁ¤Ï¡¢SIGMA-Algrich¼Ò¤è¤êÈÎÇ䤵¤ì¤Æ¤¤¤ë GPxɸÉʤάÄê¤Ë¤âÍѤ¤¤é¤ì¤Æ¤¤¤Þ¤¹¡£¾°¡¢¹ÚÁdzèÀ­¤Ï²¹ÅÙ¤ª¤è¤ÓpH¤Î±Æ¶Á¤ò¼õ¤±¤Þ¤¹¡£GPx-1¤Ë´Ø¤·¤Æ¤Ï ²¹ÅÙ1¡î¤Î°ã¤¤¤Ç5¡óÄøÅÙ¤Î¸íº¹¤¬À¸¤¸¤Þ¤¹¡£¤Þ¤¿¡¢pH8.8¤Ë¤ª¤±¤ë¹ÚÁdzèÀ­¤ÏpH7.0¤Ç¬Äꤷ¤¿ÃͤÎÌó10ÇܤÎÃͤò¼¨¤·¤Þ¤¹¡£
3 GPxɸÉʤÎÆþ¼êÀè ¥°¥ë¥¿¥Á¥ª¥ó¥Ú¥ë¥ª¥­¥·¥À¡¼¥¼¡ÊGPx¡ËɸÉʤÏSIGMA-Aldrich¼Ò¤è¤êÆþ¼ê²Äǽ¤Ç¤¹¡£
Glutathione Peroxidase from bovine erythrocytes, 300-700 units/mg protein (code:G6137)
4 ´ûÃΤαƶÁ°ø»Ò¤Ë¤Ä¤¤¤Æ ËÜ¥­¥Ã¥È¤Ï²¼µ­¤ÎÔó»¨Êª¼Á¤Î±Æ¶Á¤ò¼õ¤±¤ë¾ì¹ç¤¬¤¢¤ê¤Þ¤¹¡£
¡¦´Ô¸µºÞ¡§ 0.1mM°Ê¾å¤ÎÇ»ÅÙ¤Îcysteine¡¢¦Â-mercaptoethanol¡¢dithiothreitol¤Ê¤É¤Î´Ô¸µºÞ¡£
¡¦340nm¤Ë¤ª¤±¤ëµÛ¼ý¡§ ¥µ¥ó¥×¥ë¤Î340nm¤Ë¤ª¤±¤ëµÛ¼ý¤Ï1.2¤òĶ¤¨¤Ê¤¤¤è¤¦¤Ë¤·¤Æ¤¯¤À¤µ¤¤¡£
¡¦²á¾ê¤ÊGSSG¡§¥µ¥ó¥×¥ë¤Ë²á¾ê¤ÎGSSG¤¬´Þ¤Þ¤ì¤ë¤ÈGPx³èÀ­¤¬¹â¤á¤Ë¸¡½Ð¤µ¤ì¤Þ¤¹¡£GSSG¤ÏÆ©ÀϤˤè¤ê½üµî²Äǽ¤Ç¤¹¡£
¡¦NADPH¤ò¾ÃÈñ¤¹¤ë¹ÚÁÇ¡§¥µ¥ó¥×¥ëÃæ¤ËNADPH¤ò¾ÃÈñ¤¹¤ë¹ÚÁǤ¬´Þ¤Þ¤ì¤ë¤È¡¢GPx³èÀ­¤¬¹â¤á¤Ë¸¡½Ð¤µ¤ì¤Þ¤¹¡£
¡¦Tween-20¤äTriton X-100¤È¤¤¤Ã¤¿polyethoxy·ÏÈ󥤥ª¥óÀ­³¦Ì̳èÀ­ºÞ¤ÏËÜ¥­¥Ã¥È¤Ë±Æ¶Á¤òÍ¿¤¨¤ë¾ì¹ç¤¬¤¢¤ê¤Þ¤¹¡£
5 ·ìÀ¶¥µ¥ó¥×¥ë¤ÎÊݸÊýË¡ -70¡î¤Ç¤ÎÅà·ëÊݸ¤ò¤ª¾©¤á¤·¤Þ¤¹¡£
6 NADPH»îÌô¤ÎÊݸ Íϲò¸å¤ÎNADPH»îÌô¤ÎÍ­¸ú´ü¸Â¤Ï72»þ´Ö¤Ç¤¹¡£Íϲò¸å¤ÏÅà·ëÊݸ¤Ç¤­¤Þ¤»¤ó¤Î¤Ç¤´Ãí°Õ¤¯¤À¤µ¤¤¡£ 1¥Ð¥¤¥¢¥ë¤òʬ¤±¤ÆÍϲò¤¹¤ë¤³¤È¤Ï¤Ç¤­¤Þ¤»¤ó¡£1ËܤÎNADPH»îÌô¤ò1ËܤÎNADPHÍϲò±ÕÁ´Î̤ò»È¤Ã¤ÆÍϲò¤·¤Æ¤¯¤À¤µ¤¤¡£
7 ·üÂù±Õ¤ÎÄ´À½Îã 50 mM Tris,5 mM EDTA, 1 mM DTT or 2-ME, pH 7.5
¤´¼ÁÌä¤Ê¤É¤ªµ¤·Ú¤Ë¤É¤¦¤¾¡Ê¥á¡¼¥ë¡Ë À½ÉʾðÊó¤ËÌá¤ë
¡Ú»²¹Íʸ¸¥¡Û
1) Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med.70(1),p158-169(1967), Paglia DE, Valentine WN.
2) Type II skeletal myofibers possess unique properties that potentiate mitochondrial H2O2 generation. Am J Physiol Cell Physiol 290,C844-851(2006), Anderson, EJ and Neufer, PD
ËÜ¥­¥Ã¥È¤ò»ÈÍѤ·¤¿Â¬ÄêÎã¤Ç¤¹
3) Determination of selenium concentration and glutathione peroxidase activity in plasma and erythrocytes. Clin Chem 28(2),p311-316(1982), Pleban PA, Munyani A, Beachum J.
ÀÖ·ìµåÃæ¤Î¥°¥ë¥¿¥Á¥ª¥ó¥Ú¥ë¥ª¥­¥·¥À¡¼¥¼³èÀ­¤Î¬ÄêÎã¤Ç¤¹
4) Glutathione Peroxidase Enzyme Activity in Aging. J Gerontol 63A(5), p505-509 (2008) Sara E. Espinoza, Hongfei Guo, Neal Fedarko, Amy DeZern, Linda P. Fried, Qian-Li Xue, Sean Leng, Brock Beamer, and Jeremy D. Walston
Women¡Çs Health and Aging Study (WHAS)¡£ÃæÄøÅÙ¡Á¹âÅ٤οÈÂξ㳲¤ò»ý¤Ä65¡Á100¡Ê77.6¡Þ7.8¡ËºÐ¤Î½÷À­601̾¤Ë¤ª¤¤¤Æ Á´·ì¤Î¥°¥ë¥¿¥Á¥ª¥ó¥Ú¥ë¥ª¥­¥·¥À¡¼¥¼³èÀ­Â¬ÄêÃͤϡ¢Ç¯Îð¤È¤Î´Ö¤ÇÍ­°Õ¤ËÉé¤ÎÁê´Ø¡Êp < 0.001¡Ë¤ò¼¨¤¹¤³¤È¤¬Êó¹ð¤µ¤ì¤Æ¤¤¤Þ¤¹¡£
5) Methylmercury neurotoxicity is associated with inhibition of the antioxidant enzyme glutathione peroxidase. Free Radical Biology and Medicine 47(4), p449-457(2009) Jeferson L. Franco, Thais Posser, Peter R. Dunkley, Phillip W. Dickson, Jaco J. Mattos, Roberta Martins, Afonso C.D. Bainy, Maria R. Marques, Alcir L. Dafre and Marcelo Farina
¥á¥Á¥ë¿å¶ä¤Ë¤è¤ë¿À·ÐÆÇÀ­¤Ë¤ª¤¤¤Æ¡¢¥°¥ë¥¿¥Á¥ª¥ó¥Ú¥ë¥ª¥­¥·¥À¡¼¥¼¤¬½ÅÍפÊɸŪʬ»Ò¤Ç¤¢¤ë¤³¤È¤¬¼¨º¶¤µ¤ì¤Æ¤¤¤Þ¤¹¡£
¤´¼ÁÌä¤Ê¤É¤ªµ¤·Ú¤Ë¤É¤¦¤¾¡Ê¥á¡¼¥ë¡Ë À½ÉʾðÊó¤ËÌá¤ë
¥°¥ë¥¿¥Á¥ª¥ó¥ì¥À¥¯¥¿¡¼¥¼(GR)¬Äꥭ¥Ã¥È
No. ¡Ú¥¿¥¤¥È¥ë¡Û ¡ÚÆâÍÆ¡Û
1 ·ìÀ¶¥µ¥ó¥×¥ë¤Ø¤ÎŬÍÑ ¥¬¥ó´µ¼Ô¤Ë¤ª¤¤¤Æ¡¢·ìÞù/·ìÀ¶Ãæ¤ÎGR³èÀ­¤¬¹âÃͤò¼¨¤¹¤³¤È¤¬Êó¹ð¤µ¤ì¤Æ¤¤¤Þ¤¹¤¬¡¢·ò¾ï¼Ô¤Ç¤Ï·ìÞù/·ìÀ¶Ãæ¤ÎGR³èÀ­¤Ï ¸¡½Ð¤µ¤ì¤Ê¤¤¤è¤¦¤Ç¤¹¡£Â¬Äê¤ÎºÝ¤Ë¤Ï¡¢ÍÏ·ì¤Ë¤è¤Ã¤ÆÀÖ·ìµåGR¤Î±Æ¶Á¤¬½Ð¤ë²ÄǽÀ­¤¬¤¢¤ê¤Þ¤¹¤Î¤Ç¡¢¤´Ãí°Õ¤¯¤À¤µ¤¤¡£
2 ¥Ø¥â¥°¥í¥Ó¥óÇ»Å٤άÄêË¡ ¥Ø¥â¥°¥í¥Ó¥óÇ»Å٤άÄêË¡¤È¤·¤Þ¤·¤Æ¤Ï¥·¥¢¥ó¥á¥È¥Ø¥â¥°¥í¥Ó¥óË¡¤¬ÃΤé¤ì¤Æ¤¤¤Þ¤¹
Îã¡ËBioAssay System¼Ò Hemoglobin Assay Kit, QuantiChrom (250 tests) ¥Õ¥Ê¥³¥·°·
3 ±Æ¶Á°ø»Ò¤Ë¤Ä¤¤¤Æ ÀºÀ½¤·¤¿GR¤Ï¡¢Zn++¤Þ¤¿¤ÏCd++¤Î¸ºß²¼¤ÇNADPH¡¢NADH¡¢¥°¥ë¥¿¥Á¥ª¥ó¡¢ S2O42-¡¢NaBH4¤Ë¤è¤êÉԳ貽¤µ¤ì¤ë¤³¤È¤¬ ÃΤé¤ì¤Æ¤ª¤ê¡¢¤³¤ÎÉԳ貽¤ÏEDTA¤Îź²Ã¤Ë¤è¤êËɤ°¤³¤È¤¬¤Ç¤­¤Þ¤¹¡£¤Þ¤¿¡¢Î²»À¥¢¥ó¥â¥Ë¥¦¥à¡Ê¡æ100mM¡Ë¤ÏGR³èÀ­¤òÁ˳²¤·¤Þ¤¹¡£ ¤Þ¤¿¡¢¹âÇ»Å٤Υإ⥰¥í¥Ó¥ó¡Ê¡æ1mg/mL¡Ë¤Ï340nm¤Ë¤ª¤±¤ëµÛ¼ý¤ò¼¨¤¹¤¿¤á¡¢Â¬Äê¤Ë±Æ¶Á¤òÍ¿¤¨¤ë¾ì¹ç¤¬¤¢¤ê¤Þ¤¹¡£ ¾°¡¢¥Ý¥ê¥Ó¥Ë¥ë¥Ô¥í¥ê¥É¥ó¡Ê0.1¡ó¡Ë¡¢KCl¡Ê100mM¡Ë¡¢Ç¢ÁÇ¡Ê600mM¡Ë¡¢Triton X-100¡Ê0.1¡ó¡Ë¤ÏËÜ¥­¥Ã¥È¤Ë±Æ¶Á¤·¤Þ¤»¤ó¡£
4 ¹ÚÁdzèÀ­¤ÎÄêµÁ ËÜ¥­¥Ã¥È¤Ë¤ª¤±¤ëGR³èÀ­¤ÎÄêµÁ¤Ï¡¢25¡î¡¢pH7.6¤Ë¤ª¤¤¤Æ1ʬ´Ö¤Ë1¦Ì¥â¥ë¤ÎGSSG¤òʬ²ò¤¹¤ëGR³èÀ­¤ò1unit¤È¤·¤Þ¤¹¡£
5 GR³èÀ­¤Î²¹Åٰ͸À­¤Ë¤Ä¤¤¤Æ GR³èÀ­¤Ï²¹Å٤αƶÁ¤ò¼õ¤±¤Þ¤¹¡£25¡î¤Ë¤ª¤±¤ë¹ÚÁdzèÀ­¤ò100¡ó¤È¤·¤¿¾ì¹ç¡¢15¡î¤Ç¤Ï46¡ó¡¢20¡î¤Ç¤Ï68¡ó¡¢30¡î¤Ç¤Ï133¡ó¡¢ 35¡î¤Ç¤Ï172¡ó¤Î³èÀ­¤ò¼¨¤·¤Þ¤¹¡£NADPH¤Îʬ»ÒµÛ¸÷·¸¿ô¤«¤é¹ÚÁdzèÀ­¤ò»»½Ð¤¹¤ëºÝ¤Ë¤Ï¤´Ãí°Õ¤¯¤À¤µ¤¤¡£
ÊäÀµ·¸¿ô¦Ä¤Ï¼¡¤Î¼°¤Çµá¤á¤ë¤³¤È¤¬¤Ç¤­¤Þ¤¹¡£¦Ä= 0.0062 x T 1.578
T¤Ï²¹ÅÙ¡Êñ°Ì¡§¡î¡Ë¤Ç¤¹¡£Î㤨¤Ð27.5¡î¤Ç¬Äꤷ¤¿¹ÚÁdzèÀ­Â¬ÄêÃͤ¬449 mU/mL¤Î¾ì¹ç¡¢²¼µ­¤Î¤è¤¦¤ËÊäÀµ¤Ç¤­¤Þ¤¹¡£
ÊäÀµ¸å¤ÎGR³èÀ­ ¡á 0.0062 x 27.51.578 x 449 ¡á 520 (mU/mL)
6 ¥Ø¥â¥°¥í¥Ó¥óÇ»Å٤ˤĤ¤¤Æ ¥Ø¥â¥°¥í¥Ó¥ó¤Ï¡¢ËÜ¥­¥Ã¥È¤Î¬ÄêÇÈŤǤ¢¤ë340nm¤Ë¤ª¤¤¤Æ¶¯¤¤µÛ¼ý¤ò¼¨¤¹¤¿¤á¡¢¤ª»È¤¤¤Ë¤Ê¤ë¥Þ¥¤¥¯¥í¥×¥ì¡¼¥È¥ê¡¼¥À¡¼¤ä ʬ¸÷¸÷Åٷפε¡¼ï¤Ë¤è¤Ã¤Æ¤Ï¡¢¹âÇ»Å٤Υإ⥰¥í¥Ó¥ó¤¬Â¬Äê¤ò˸³²¤¹¤ë¡ÊµÛ¸÷ÅÙ¤¬¥ì¥ó¥¸³°¤Ë¤Ê¤ë¡Ë¾ì¹ç¤¬¤¢¤ê¤Þ¤¹¡£ ¤½¤Î¤è¤¦¤Ê¾ì¹ç¤Ë¤Ï¡¢È¿±þ±ÕÃæ¤Î¥Ø¥â¥°¥í¥Ó¥óÇ»ÅÙ¤¬1mg/mL°Ê²¼¤È¤Ê¤ë¤è¤¦¡¢Ä´À°¤¹¤ë¤³¤È¤ò¤ª¾©¤á¤·¤Þ¤¹¡£
¤´¼ÁÌä¤Ê¤É¤ªµ¤·Ú¤Ë¤É¤¦¤¾¡Ê¥á¡¼¥ë¡Ë À½ÉʾðÊó¤ËÌá¤ë
¡Ú»²¹Íʸ¸¥¡Û
1) On the reaction mechanism of yeast glutathione reductase.
J Biol Chem. 240(11),p4470-4480(1965), Massey V, Williams CH Jr.
2) Glutathione reductase from human erythrocytes. Catalytic properties and aggregation.
Eur J Biochem.67(1),p231-238 (1976), Worthington DJ, Rosemeyer MA.
3) Effect of flavin compounds on glutathione reductase activity: in vivo and in vitro studies.
J Clin Invest.48(10), p1957-1966(1969), Beutler E.
4) A biochemical evaluation of the erythrocyte glutathione reductase (EC 1.6.4.2) test for riboflavin status. 2 Dose-response relationships in chronic marginal deficiency.
Br J Nutr. 45(1),p53-65(1981), Prentice AM, Bates CJ.
5) The effect of riboflavin deficiency on white cell glutathione reductase in rats.
Int J Vitam Nutr Res.47(1),p46-51(1977), Muller EM, Bates CJ.
6) Glutathione reductase in human lens epithelium: FAD-induced in vitro activation.
Curr Eye Res.6(10),p1249-1256(1987), Horwitz J, Dovrat A, Straatsma BR, Revilla PJ, Lightfoot DO.
7) Glutathione reductase from human erythrocytes. Molecular weight, subunit composition and aggregation properties.
Eur J Biochem. 60(2), p459-466 (1975), Worthington DJ, Rosemeyer MA.
8) Regulation of horse-liver glutathione reductase.
Int J Biochem. 25(4),p513-520(1993), Garcia-Alfonso C, Martinez-Galisteo E, Llobell A, Barcena JA, Lopez-Barea J.
9) Glutathione reductase.
Methods Enzymol. 113,p484-490(1985), Carlberg I, Mannervik B.
10) Assay of glutathione reductase in crude tissue homogenates using 5,5'-dithiobis(2-nitrobenzoic acid).
Anal Biochem. 175(2),p408-413(1988), Smith IK, Vierheller TL, Thorne CA.
11) Glutathione-peroxidase and glutathione-reductase activities of normal and pathologic human liver: relationship with age.
Scand J Gastroenterol. 15(7),p781-786(1980), Corrocher R, Casaril M, Guidi C, Gabrielli GB, Miatto O, De Sandre G.
12) An optimized semi-automatic rate method for serum glutathione reductase activity and its application to patients with malignant disease.
J Clin Pathol. 29(1),p73-77(1976), Delides A, Spooner RJ, Goldberg DM, Neal FE.
¤´¼ÁÌä¤Ê¤É¤ªµ¤·Ú¤Ë¤É¤¦¤¾¡Ê¥á¡¼¥ë¡Ë À½ÉʾðÊó¤ËÌá¤ë
¥Ò¥È ¥Á¥ª¥ì¥É¥­¥·¥ó´Ô¸µ¹ÚÁÇ-1¡Ê¥Á¥ª¥ì¥É¥­¥·¥ó ¥ì¥À¥¯¥¿¡¼¥¼-­µ¡Ë¬Äꥭ¥Ã¥È
No. ¡Ú¥¿¥¤¥È¥ë¡Û ¡ÚÆâÍÆ¡Û
1 ·ìÞù¥µ¥ó¥×¥ë¤Ë¤Ä¤¤¤Æ ·ìÞùºÎ¼è»þ¤Î¹³¶Å¸ÇºÞ¤ÏEDTA¤Þ¤¿¤Ï¥Ø¥Ñ¥ê¥ó¤¬»ÈÍѤǤ­¤Þ¤¹¡£·ìÞùʬΥ¸å¤ÏÅà·ëÊݸ¡Ê-70¡î¡Ë¤ò ¤ª¾©¤á¤·¤Þ¤¹¡£Åà·ëÍ»²ò¤Î·«¤êÊÖ¤·¤ÏÈò¤±¤Æ¤¯¤À¤µ¤¤¡£
2 ¥¹¥¿¥ó¥À¡¼¥É¤ÎÊݸÊýË¡ ºÆ¹½À®¸å¤Î¥¹¥¿¥ó¥À¡¼¥É¤ÏÉÔ°ÂÄê¤Ê¤¿¤áÎä¢Êݸ¤Ç¤­¤Þ¤»¤ó¡£Êݸ¤¹¤ë¾ì¹ç¤Ë¤Ï¡¢Åà·ëÊݸ¡Ê-70¡î¡Ë¤ò ¤ª¾©¤á¤·¤Þ¤¹¡£Åà·ëÍ»²ò¤Ï1²ó¤Î¤ß²Äǽ¤Ç¤¹¡£
¤´¼ÁÌä¤Ê¤É¤ªµ¤·Ú¤Ë¤É¤¦¤¾¡Ê¥á¡¼¥ë¡Ë
¡Ú»²¹Íʸ¸¥¡Û
1) Thioredoxin reductase. Biochem J. 346(1),p1-8(2000). Mustacich D, Powis G
2) Thioredoxin reductase as a novel molecular target for cancer therapy.
Cancer Lett. 236(2),p164-174 (2006). Nguyen P, Awwad RT, Smart DD, Spitz DR, Gius D.
3) On the potential of thioredoxin reductase inhibitors for cancer therapy.
Semin Cancer Biol 16(6),p452-465 (2006). Urig S, Becker K.
4) Thioredoxin reductase, a redox-active selenoprotein, is secreted by normal and neoplastic cells: presence in human plasma. Cancer Res 60(8),p2281-2289 (2000). Soderberg A, Sahaf B, Rosen A
¥Ò¥È ¥Á¥ª¥ì¥É¥­¥·¥ó-1¬Äꥭ¥Ã¥È
No. ¡Ú¥¿¥¤¥È¥ë¡Û ¡ÚÆâÍÆ¡Û
1
¤´¼ÁÌä¤Ê¤É¤ªµ¤·Ú¤Ë¤É¤¦¤¾¡Ê¥á¡¼¥ë¡Ë
¡Ú»²¹Íʸ¸¥¡Û
1) Protein disulfide-isomerase is a substrate for thioredoxin reductase and has thioredoxin-like activity. Lundstrom J, Holmgren A: J Biol Chem 265(16), p9114-9120 (1990)
2) Thioredoxin regulates the DNA binding activity of NF-kappa B by reduction of a disulphide bond involving cysteine 62. Matthews JR, Wakasugi N, Virelizier JL, Yodoi J, Hay RT: Nucleic Acids Res 20(15), p3821-3830(1992)
3) Isoforms of mammalian peroxiredoxin that reduce peroxides in presence of thioredoxin.
Chae HZ, Kang SW, Rhee SG: Methods Enzymol 300, p219-226 (1999)
4) Physiological functions of thioredoxin and thioredoxin reductase.
Arner ES, Holmgren A: Eur J Biochem 267(20), p6102-6109 (2000)
5) Thioredoxin nuclear translocation and interaction with redox factor-1 activates the activator protein-1 transcription factor in response to ionizing radiation. Wei SJ, Botero A, Hirota K, Bradbury CM, Markovina S, Laszlo A, Spitz DR, Goswami PC, Yodoi J, Gius D: Cancer Res 60(23),p6688-6695 (2000)
6) Reactive oxygen species, antioxidants, and the mammalian thioredoxin system.
Nordberg J, Arner ES: Free Radic Biol Med 31(11), p1287-1312 (2001)
7) The roles of thioredoxin in protection against oxidative stress-induced apoptosis in SH-SY5Y cells. Andoh T, Chock PB, Chiueh CC: J Biol Chem 277(12), p9655-9660 (2002)
8) From oxygen sensing to heart failure: role of thioredoxin. Hoshino Y, Shioji K, Nakamura H, Masutani H, Yodoi J: Antioxid Redox Signal 9(6),p689-699 (2007)
¥Ò¥ÈMn-SOD (SOD2)¬ÄêÍÑELISA¥­¥Ã¥È
No. ¡Ú¥¿¥¤¥È¥ë¡Û ¡ÚÆâÍÆ¡Û
1 ¥Ò¥È°Ê³°¤Îưʪ¤ËŬÍѤǤ­¤Þ¤¹¤«¡© ËÜ¥­¥Ã¥È¤Ï¥Ò¥ÈͳÍèMn-SOD (SOD2)¤ËÆðÛŪ¤Ç¤¹¡£ ¥é¥Ã¥ÈSOD2¤ä¥Þ¥¦¥¹SOD2¤È¤Î¸òº¹È¿±þÀ­¤¬¤Ê¤¤¤³¤È¤¬³Îǧ¤µ¤ì¤Æ¤¤¤Þ¤¹¡£
¤´¼ÁÌä¤Ê¤É¤ªµ¤·Ú¤Ë¤É¤¦¤¾¡Ê¥á¡¼¥ë¡Ë
À½ÉʾðÊó¤ËÌá¤ë
¡Ú»²¹Íʸ¸¥¡Û
1) Manganese activation of superoxide dismutase 2 in the mitochondria of Saccharomyces cerevisiae.
J Biol Chem 280(24),p22715-22720 (2005). Luk E, Yang M, Jensen LT, Bourbonnais Y, Culotta VC
2) Invited review: manganese superoxide dismutase in disease. Free Radic Res 34(4), p325-336 (2001). Macmillan-Crow LA, Cruthirds DL
3) Superoxide dismutase multigene family: a comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression. Free Radic Biol Med 33(3), p337-349 (2002). Zelko IN, Mariani TJ, Folz RJ.
4) The copper chaperone CCS directly interacts with copper/zinc superoxide dismutase.
J Biol Chem 273(37), p23625-23628 (1998). Casareno RL, Waggoner D, Gitlin JD
5) Human extracellular superoxide dismutase is a tetramer composed of two disulphide-linked dimers: a simplified, high-yield purification of extracellular superoxide dismutase. Biochem J 317(Pt 1), p51-57 (1996). Oury TD, Crapo JD, Valnickova Z, Enghild JJ.
6) The structure of holo and metal-deficient wild-type human Cu, Zn superoxide dismutase and its relevance to familial amyotrophic lateral sclerosis. J Mol Biol 328(4), p877-891 (2003). Strange RW, Antonyuk S, Hough MA, Doucette PA, Rodriguez JA, Hart PJ, Hayward LJ, Valentine JS, Hasnain SS
¤´¼ÁÌä¤Ê¤É¤ªµ¤·Ú¤Ë¤É¤¦¤¾¡Ê¥á¡¼¥ë¡Ë À½ÉʾðÊó¤ËÌá¤ë
¥Ë¥È¥í¥Á¥í¥·¥ó¬Äꥭ¥Ã¥È
No. ¡Ú¥¿¥¤¥È¥ë¡Û ¡ÚÆâÍÆ¡Û
1 Immundiagnostik¼ÒÀ½ÉʤȤΰ㤤¤Ë¤Ä¤¤¤Æ ÊÀ¼Ò¤¬¼è¤ê°·¤Ã¤Æ¤ª¤ê¤Þ¤¹¥Ë¥È¥í¥Á¥í¥·¥ó¬Äꥭ¥Ã¥È¤Ë¤Ï¡¢²¼µ­¤Î£²¼ïÎब¤¢¤ê¤Þ¤¹¡£
¡¦KNT-034DT ·ìÞù¥Ë¥È¥í¥Á¥í¥·¥ó¬Äꥭ¥Ã¥È
¡¦KNT-002W  ¥Ë¥È¥í¥Á¥í¥·¥ó¬Äꥭ¥Ã¥È ¡ÊËÜÀ½ÉÊ¡Ë
¤³¤³¤Ç¤Ï¥Ë¥È¥í¥Á¥í¥·¥ó¬Äꥭ¥Ã¥È¤Ë´Ø¤¹¤ëµ»½Ñ¾ðÊó¤ò¤´¾Ò²ð¤·¤Æ¤ª¤ê¤Þ¤¹¡£¾åµ­£²¼ïÎà¤Î¥­¥Ã¥È¤Ï ¥á¡¼¥«¡¼¤¬°Û¤Ê¤Ã¤Æ¤¤¤ë¤³¤È¤«¤é¡¢¸¡½ÐÆÃÀ­¡Ê¬ÄêÃÍ¡¢Áê´ØÀ­¤Ê¤É¡Ë¤¬°Û¤Ê¤ë¾ì¹ç¤¬¤¢¤ê¤Þ¤¹¤Î¤Ç¤´Î±°Õ¤¯¤À¤µ¤¤¡£
¾°¡¢KNT-034DT ·ìÞù¥Ë¥È¥í¥Á¥í¥·¥ó¬Äꥭ¥Ã¥È¤Îµ»½Ñ¾ðÊó¤Ë´Ø¤·¤Þ¤·¤Æ¤Ï¡¢ ¤³¤Á¤é¤ò¤´»²¾È¤¯¤À¤µ¤¤¡£
2 ¥µ¥ó¥×¥ë¤ÎÊݸ°ÂÄêÀ­ -70¡îÅà·ëÊݸ¤Ç¤ÏÈó¾ï¤Ë°ÂÄê¤Ç¤¢¤ë¤È¤µ¤ì¤Æ¤¤¤Þ¤¹¡£¥Ë¥È¥í¥Á¥í¥·¥ó¼«ÂΤÏ-20¡îÅà·ëÊݸ¤Ç 6¥ö·î¡¢-80¡îÊݸ¤Ç1ǯ´Ö°ÂÄê¤È¤µ¤ì¤Æ¤¤¤Þ¤¹¡£
3 ÁÈ¿¥¥µ¥ó¥×¥ë¤Ø¤ÎŬÍÑ ËÜ¥­¥Ã¥È¤ÏÁÈ¿¥¥µ¥ó¥×¥ë¤ËŬÍѤǤ­¤ë¾ì¹ç¤¬¤¢¤ê¤Þ¤¹¡£
1) ÁÈ¿¥¤òÞõή¤·¡¢·ì±Õ¤ò½ü¤­¤Þ¤¹
2) ÁÈ¿¥ÊÒ¤òºÎ¼è¡¢ÅöÆü¬Äꤷ¤Ê¤¤¾ì¹ç¤Ë¤Ï¤¿¤À¤Á¤Ë-80¡îÅà·ëÊݸ
3) ɹÎ䤷¤¿PBS¤òź²Ã¤·¡¢¥Û¥â¥¸¥Í¡¼¥È¤òÄ´À½¡¢±ó¿´¾åÀ¶¤ò²ó¼ý
4) ELISA¤ËŬÍѤ·¤Þ¤¹¡£1/5¡Á1/10´õ¼á¤·¤Æ¬Äꤵ¤ì¤ë¤³¤È¤¬Â¿¤¤¤è¤¦¤Ç¤¹
¡Ú»²¹Íʸ¸¥¡Û
Effects of combination therapy with vildagliptin and valsartan in a mouse model of type 2 diabetes.
Cardiovasc Diabetol 12,p160 (2013). doi: 10.1186/1475-2840-12-160.
Miyagawa K, Kondo T, Goto R, Matsuyama R, Ono K, Kitano S, Kawasaki S, Igata M, Kawashima J, Matsumura T, Motoshima H, Araki E.
¤´¼ÁÌä¤Ê¤É¤ªµ¤·Ú¤Ë¤É¤¦¤¾¡Ê¥á¡¼¥ë¡Ë À½ÉʾðÊó¤ËÌá¤ë
¡Ú»²¹Íʸ¸¥¡Û
1) Protein 3-Nitrotyrosine in Complex Biological Samples: Quantification by High-Pressure Liquid Chromatography/Electrochemical Detection and Emergence of Proteomic Approaches for Unbiased Identification of Modification Sites. Tal Nuriel, Ruba S. Deeb, David P. Hajjar, and Steven S. Gross: Methods Enzymol 441,p1-17(2008)
2) Nitrotyrosine in plasma of celiac disease patients as detected by a new sandwich ELISA.
Steege JC, Koster-Kamphuis L, van Straaten EA, Forget PP, Buurman WA. Free Radic Biol Med 25(8), p953-963 (1998)
¤´¼ÁÌä¤Ê¤É¤ªµ¤·Ú¤Ë¤É¤¦¤¾¡Ê¥á¡¼¥ë¡Ë À½ÉʾðÊó¤ËÌá¤ë
¥«¥¿¥é¡¼¥¼³èÀ­Â¬Äꥭ¥Ã¥È¡ÊUVË¡¡Ë
No. ¡Ú¥¿¥¤¥È¥ë¡Û ¡ÚÆâÍÆ¡Û
1 ¥µ¥ó¥×¥ë¤ÎÊݸÊýË¡ ¥«¥¿¥é¡¼¥¼¤ÏÈæ³ÓŪ°ÂÄê¤Ê¹ÚÁǤǤ¢¤ê¡¢¹âÇ»ÅÙ¡ÊHb 5g/mL°Ê¾å¤ÎÀÖ·ìµå¥é¥¤¥»¡¼¥È¡Ë¤Ç¤Ï Îä¢6Æü´Ö°ÂÄê¤Ç¤¹¡£°ìÊý¡¢´õ¼á¤·¤¿¥µ¥ó¥×¥ë¤ÏÉÔ°ÂÄê¤Ç¤¢¤ê¡¢Î㤨¤ÐHb 1.2mg/mL¤ÎÀÖ·ìµå¥é¥¤¥»¡¼¥È¤Ç¤Ï Îä¢24»þ´Ö¤Ç10¡Á15¡ó³èÀ­¤¬Äã²¼¤¹¤ë¤È¤µ¤ì¤Æ¤¤¤Þ¤¹¡£
¤Þ¤¿¡¢Åà·ëÊݸ¤Ë¤Ä¤¤¤Æ¤âÃí°Õ¤¬É¬ÍפǤ¹¡£-20¡î¤ÎÅà·ëÊݸ¤Ç¤Ï¡¢¹âÇ»ÅÙ¤ÎÀÖ·ìµå¥é¥¤¥»¡¼¥È¤¢¤Ã¤Æ¤â 40¡ó¤Î¼º³è¤¬µ¯¤­¤ë¤È¤µ¤ì¤Æ¤¤¤Þ¤¹¡£Åà·ëÊݸ¤ÎºÝ¤Ï¹âÇ»Å٤Υµ¥ó¥×¥ë¤ò-70¡î°Ê²¼¤Ç¤ÎÊݸ¤¹¤ë¤è¤¦¤Ë ¤·¤Æ¤¯¤À¤µ¤¤¡£
2 ÇÝÍܺÙ˦¤Ø¤ÎŬÍѤˤĤ¤¤Æ ´ðËÜŪ¤Ë¤ÏÁÈ¿¥¥Û¥â¥¸¥Í¡¼¥È¤ÈƱÍͤÎÊýË¡¤Ë¤Æ¬Äê¤Ç¤­¤ë¤È¹Í¤¨¤é¤ì¤Þ¤¹¤¬¡¢ ºÙ˦¤Î¼ïÎà¤Ë¤è¤ê¥«¥¿¥é¡¼¥¼¤Îȯ¸½Î̤ϰۤʤ뤿¤á¡¢Í½¤áͽÈ÷¼Â¸³Åù¤Ç³Îǧ¤µ¤ì¤ë¤³¤È¤ò¤ª¾©¤á¤·¤Þ¤¹¡£
3 ´õ¼á¥Ð¥Ã¥Õ¥¡¡¼¤Ë¤Ä¤¤¤Æ ¥­¥Ã¥È¤ËƱº­¤µ¤ì¤Æ¤¤¤ë¥µ¥ó¥×¥ë´õ¼á¥Ð¥Ã¥Õ¥¡¡¼¤Ë¤Ï¡¢¥«¥¿¥é¡¼¥¼¤ò°ÂÄê²½¤¹¤ë¸ú²Ì¤¬ ¤¢¤ê¤Þ¤¹¤Î¤Ç¡¢¥µ¥ó¥×¥ë¤Î´õ¼á¤Ë¤Ï¥µ¥ó¥×¥ë´õ¼á¥Ð¥Ã¥Õ¥¡¡¼¤ò¤´»ÈÍѤ¯¤À¤µ¤¤¡£
´õ¼á¤·¤¿¥µ¥ó¥×¥ë¤Ï¼¼²¹¤Ë¤Æ15ʬÀÅÃÖ¤·¤Æ¤«¤é¡¢Â¬Äꤷ¤Æ¤¯¤À¤µ¤¤¡£
¥Û¥â¥¸¥Í¡¼¥È¤ÎÄ´À½¤Ë¤Ï10mM PBS¤â»ÈÍѲÄǽ¤Ç¤¹¡£
4 µÛ¸÷Å٤άÄê´Ö³Ö ËÜ¥­¥Ã¥È¤ÏÈ¿±þ»þ´Ö¤¬Èæ³ÓŪû¤¯¡¢»îÌôź²Ã¸å30¡Á60ÉäÇÈ¿±þ®ÅÙ¡Ê»þ´ÖÅö¤¿¤ê¤ÎµÛ¸÷ÅÙÊѲ½¡Ë¤¬ ¸º¿ê¤ò»Ï¤á¤Þ¤¹¡£¤³¤Î¤¿¤á¡¢»îÌôź²Ã¸å¤Ï®¤ä¤«¤Ë¡Ê10ÉÃÄøÅ١˵۸÷ÅÙ¬Äê¤ò³«»Ï¡¢¤Ç¤­¤ì¤Ð2Éôֳ֤ǵ۸÷ÅÙ¤ò ¬Äꤷ¤Þ¤¹¡£¤ª»È¤¤¤Ë¤Ê¤ëµ¡¼ï¤Ë¤è¤ê¡¢2Éôֳ֤ǤάÄ꤬Æñ¤·¤¤¾ì¹ç¤¬¤¢¤ê¤Þ¤¹¤¬¡¢Â¬Äꤹ¤ë¥¦¥§¥ë¿ôÅù¤ò ¹©Éפ¹¤ë¤³¤È¤Ç5¡Á10ÉôְֳÊÆâ¤Ç¬Äꤹ¤ë¤è¤¦¤Ë¤·¤Æ¤¯¤À¤µ¤¤¡£
5 ¼õÂ÷ʬÀÏ ¥«¥¿¥é¡¼¥¼³èÀ­¤Ë¤Ä¤¤¤Æ¡¢Â¬Äê¤ò¤ª°ú¤­¼õ¤±½ÐÍè¤ë¾ì¹ç¤¬¤¢¤ê¤Þ¤¹¡£¸ÄÊ̤ˤ´ÁêÃ̤¯¤À¤µ¤¤¡£ ¬Äê¹àÌܤÎÀ­¼Á¾å¡¢´ð½àÃÍ¡¢»²¹ÍÃͤϤ¢¤ê¤Þ¤»¤ó¡£¤Þ¤¿¡¢Â¬ÄêÃͤˤϻÜÀß´Öº¹¡¢¥í¥Ã¥Èº¹¡¢¥Ð¥Ã¥Áº¹¡¢Æüº¹¤Ê¤É ¸íº¹¤¬À¸¤¸¤ë²ÄǽÀ­¤¬¤¢¤ê¤Þ¤¹¤Î¤Ç¡¢Í½¤á¤´Î»¾µ¤¯¤À¤µ¤¤¡£
¡¦¥«¥¿¥é¡¼¥¼³èÀ­Â¬Äꡧ 8,500±ß¡ÊÀÇÊÌ¡Ë¡¿·ï¡¡ºÇ¾¯¸¡Âοô10·ï
¤´¼ÁÌä¤Ê¤É¤ªµ¤·Ú¤Ë¤É¤¦¤¾¡Ê¥á¡¼¥ë¡Ë À½ÉʾðÊó¤ËÌá¤ë
¡Ú»²¹Íʸ¸¥¡Û
1) A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase.
J Biol Chem 195(1),p133-140 (1952). BEERS RF Jr, SIZER IW
2) Catalase in vitro. Methods Enzymol 105, p121-126 (1984) Aebi H.
¤´¼ÁÌä¤Ê¤É¤ªµ¤·Ú¤Ë¤É¤¦¤¾¡Ê¥á¡¼¥ë¡Ë À½ÉʾðÊó¤ËÌá¤ë
¥Ú¥ë¥ª¥­¥·¥ë¥é¥¸¥«¥ë¾Ãµî³èÀ­Â¬Äꥭ¥Ã¥È
No. ¡Ú¥¿¥¤¥È¥ë¡Û ¡ÚÆâÍÆ¡Û
1 ȯ¸÷¤¬¼å¤¤¾ì¹ç ȯ¸÷¬ÄêÃͤϡ¢²¹Å٤䬸÷»þ´Ö¤Ë°Í¸¤·¤Þ¤¹¤Î¤Ç¡¢Ä㤤¾ì¹ç¤Ë¤Ï ¼¼²¹25¡Á26¡î¡¢integration time 5ÉÃÄøÅÙ¤ÎÀßÄê¤ò¤ª»î¤·¤¯¤À¤µ¤¤¡£
2 ¥Þ¥¤¥¯¥í¥×¥ì¡¼¥È¤Ë¤Ä¤¤¤Æ ¥Þ¥¤¥¯¥í¥×¥ì¡¼¥È¤ò¤´»ÈÍѤˤʤë¾ì¹ç¤Ë¤Ï¡¢É¬¤ºÇò¿§¤Î¤â¤Î¤ò¤ª»È¤¤¤¯¤À¤µ¤¤¡£
¤´¼ÁÌä¤Ê¤É¤ªµ¤·Ú¤Ë¤É¤¦¤¾¡Ê¥á¡¼¥ë¡Ë À½ÉʾðÊó¤ËÌá¤ë
¡Ú»²¹Íʸ¸¥¡Û
1) Evaluation of total reactive antioxidant potential (TRAP) of tissue homogenates and their cytosols.
Arch Biochem Biophys. 388(2), p261-266(2001). Evelson P, Travacio M, Repetto M, Escobar J, Llesuy S, Lissi EA.
2) Evaluation of total antioxidant potential (TRAP) and total antioxidant reactivity from luminol-enhanced chemiluminescence measurements. Free Radic Biol Med. 18(2), p153-158(1995). Lissi E, Salim-Hanna M, Pascual C, del Castillo MD.
3) Total antioxidant activity measured by chemiluminescence methods.
Methods Enzymol. 299, p3-15 (1999). Alho H, Leinonen J.
¤´¼ÁÌä¤Ê¤É¤ªµ¤·Ú¤Ë¤É¤¦¤¾¡Ê¥á¡¼¥ë¡Ë À½ÉʾðÊó¤ËÌá¤ë
¥Ò¥È¥Ú¥ë¥ª¥­¥·¥ì¥É¥­¥·¥ó I (Prx-1)¬ÄêÍÑELISA¥­¥Ã¥È
No. ¡Ú¥¿¥¤¥È¥ë¡Û ¡ÚÆâÍÆ¡Û
1    
¤´¼ÁÌä¤Ê¤É¤ªµ¤·Ú¤Ë¤É¤¦¤¾¡Ê¥á¡¼¥ë¡Ë À½ÉʾðÊó¤ËÌá¤ë
¡Ú»²¹Íʸ¸¥¡Û
1) Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Rhee SG, Chae HZ, Kim K: Free Radic Biol Med 38(12),p1543-5152(2005)
2) Advances in our understanding of peroxiredoxin, a multifunctional, mammalian redox protein.
Fujii J, Ikeda Y: Redox Rep 7(3),p123-130 (2002)
3) Increased expression of mitochondrial peroxiredoxin-3 (thioredoxin peroxidase-2) protects cancer cells against hypoxia and drug-induced hydrogen peroxide-dependent apoptosis. Nonn L, Berggren M, Powis G: Mol Cancer Res 1(9),p682-689(2003).
4) Structure, mechanism and regulation of peroxiredoxins. Wood ZA, Schroder E, Robin Harris J, Poole LB: Trends Biochem Sci 28(1),p32-40(2003)
5) Structural basis of peroxiredoxin functions. Hirotsu S, Abe Y, Nishino T, Hakoshima T: PNE 45(15),p2463-2474(2000)
¤´¼ÁÌä¤Ê¤É¤ªµ¤·Ú¤Ë¤É¤¦¤¾¡Ê¥á¡¼¥ë¡Ë À½ÉʾðÊó¤ËÌá¤ë
¥Ò¥È¥Ú¥ë¥ª¥­¥·¥ì¥É¥­¥·¥ó III (Prx-3)¬ÄêÍÑELISA¥­¥Ã¥È
No. ¡Ú¥¿¥¤¥È¥ë¡Û ¡ÚÆâÍÆ¡Û
1    
¤´¼ÁÌä¤Ê¤É¤ªµ¤·Ú¤Ë¤É¤¦¤¾¡Ê¥á¡¼¥ë¡Ë
¡Ú»²¹Íʸ¸¥¡Û
1)
¤´¼ÁÌä¤Ê¤É¤ªµ¤·Ú¤Ë¤É¤¦¤¾¡Ê¥á¡¼¥ë¡Ë
ºÙ˦¼Á¥°¥ë¥¿¥Á¥ª¥ó¥Ú¥ë¥ª¥­¥·¥À¡¼¥¼Â¬ÄêÍÑELISA¥­¥Ã¥È
No. ¡Ú¥¿¥¤¥È¥ë¡Û ¡ÚÆâÍÆ¡Û
1    
¤´¼ÁÌä¤Ê¤É¤ªµ¤·Ú¤Ë¤É¤¦¤¾¡Ê¥á¡¼¥ë¡Ë
¡Ú»²¹Íʸ¸¥¡Û
1)
¤´¼ÁÌä¤Ê¤É¤ªµ¤·Ú¤Ë¤É¤¦¤¾¡Ê¥á¡¼¥ë¡Ë
¥Ò¥Èec-SOD¬Äꥭ¥Ã¥È
No. ¡Ú¥¿¥¤¥È¥ë¡Û ¡ÚÆâÍÆ¡Û
1    
¤´¼ÁÌä¤Ê¤É¤ªµ¤·Ú¤Ë¤É¤¦¤¾¡Ê¥á¡¼¥ë¡Ë
¡Ú»²¹Íʸ¸¥¡Û
1)
¤´¼ÁÌä¤Ê¤É¤ªµ¤·Ú¤Ë¤É¤¦¤¾¡Ê¥á¡¼¥ë¡Ë
MPO³èÀ­Â¬ÄêÍÑELISA¥­¥Ã¥È
No. ¡Ú¥¿¥¤¥È¥ë¡Û ¡ÚÆâÍÆ¡Û
1 ¬ÄêÇÈĹ 405nm¤Ç¤â¬Äê²Äǽ¤Ç¤¹¡£
2 ÁÈ¿¥¤Ø¤ÎŬÍÑÎã ËÜ¥­¥Ã¥È¤Ï¡¢¥Ò¥È¤À¤±¤Ç¤Ê¤¯¥Þ¥¦¥¹Åù¤Î¼Â¸³Æ°ÊªÍ³Í襵¥ó¥×¥ë¤Ë¤âŬÍѲÄǽ¤Ç¤¹¡£
3 ·ìÀ¶¤Ø¤ÎŬÍÑ ·ìÀ¶¤ª¤è¤Ó·ìÞùEDTA¤Ø¤ÎŬÍѤϲÄǽ¤Ç¤¹¤¬¡¢MPOÇ»ÅÙ¤ÏÈó¾ï¤ËÄ㤤¤È¹Í¤¨¤é¤ì¤Þ¤¹¡£ ¬Äê²¹ÅÙ¤ò¡¢37°¤Ë¾å¤²¤Æ¬Äꤹ¤ëÊýË¡¤â¤¢¤ê¤Þ¤¹¡£
4 ²á»À²½¿åÁÇ»îÌô¤ò
¤³¤Ü¤·¤Æ¤·¤Þ¤Ã¤¿¤Î¤Ç¤¹¤¬
3¡ó H2O2¡¿¾øα¿å¤Ë¤Æ¤ª»î¤·¤¯¤À¤µ¤¤¡£ ¾°¡¢¥­¥Ã¥ÈƱº­»îÌô°Ê³°¤Î»îÌô¤ò»ÈÍѤµ¤ì¤Þ¤¹¤È¡¢Â¬Äê¤Ç¤­¤Ê¤¤¡¢¤Þ¤¿¤Ï»îÌôÀ­Ç½¤¬½½Ê¬¤Ëȯ´ø¤Ç¤­¤Ê¤¤ ²ÄǽÀ­¤¬¤¢¤ê¤Þ¤¹¤Î¤Ç¡¢Í½¤á¤´Î»¾µ¤¯¤À¤µ¤¤¡£
5 Taurine solution Taurine¼«ÂΤÏAssay buffer¤Ë´Þ¤Þ¤ì¤Æ¤ª¤ê¤Þ¤¹¤Î¤Ç¡¢Ä̾ï¤ÎÁÈ¿¥¥µ¥ó¥×¥ë¤Ç¤Ï ɬÍפ¢¤ê¤Þ¤»¤ó¡£
¤´¼ÁÌä¤Ê¤É¤ªµ¤·Ú¤Ë¤É¤¦¤¾¡Ê¥á¡¼¥ë¡Ë
¡Ú»²¹Íʸ¸¥¡Û
1) Biodiesel versus diesel exposure: Enhanced pulmonary inflammation, oxidative stress, and differential morphological changes in the mouse lung. Naveena Yanamala, Meghan K. Hatfield, Mariana T. Farcas, Diane Schwegler-Berry, Jon A. Hummer, Michael R. Shurin, M. Eileen Birch, Dmitriy W. Gutkin, Elena Kisin, Valerian E. Kagan, Aleksandar D. Bugarski, Anna A. Shvedova:
Toxicology and Applied Pharmacology 272(2),p373-383(2013)
¥Þ¥¦¥¹ÇÙÁÈ¿¥¤Ø¤ÎŬÍÑÎã
2) Chlorination of taurine by human neutrophils. Evidence for hypochlorous acid generation.
Weiss SJ, Klein R, Slivka A, Wei M: J Clin Invest 70(3),p598-607(1982).
ËÜ¥­¥Ã¥È¤Î¬Ä긶Íý¤Ë´Ø¤¹¤ëʸ¸¥¤Ç¤¹
¤´¼ÁÌä¤Ê¤É¤ªµ¤·Ú¤Ë¤É¤¦¤¾¡Ê¥á¡¼¥ë¡Ë
¥Ú¡¼¥¸¤ÎÀèƬ¤Ø